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Abstract

PATIENT PERCEPTIONS OF SHARED DECISION MAKING: WHAT DOES IT MEAN
AND HOW DOES IT AFFECT PATIENT OUTCOMES?
By Laura Aubree Shay, Ph.D., M.S.S.W.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2013.
Major Director: Jennifer Elston Lafata, Ph.D.
Professor, Department of Social and Behavioral Health

Introduction: Shared decision making (SDM) has been advocated as an optimal approach to
medical decision-making. Yet, little is known about how patients perceive SDM and whether
patient-defined SDM is associated with patient outcomes.
Methods: This three-manuscript dissertation used a mixed-methods approach including a
systematic literature review and both qualitative and quantitative research methods. The aims
were to: (1) systematically review the patient outcomes studied in relation to SDM and identify
under what measurement contexts SDM is associated with which types of patient outcomes; (2)
use in-depth, qualitative interviews to develop a conceptual model of patient-defined SDM and
compare this to recent decisions that patients labeled as shared; and (3) apply the model of
patient-defined SDM to the context of colorectal cancer screening.
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Results: Study 1 found that 39 studies measured SDM and evaluated it with a patient outcome,
and only 43% of patient outcomes assessed were significantly associated with SDM. Patient
reports of SDM were most likely to be associated with outcomes.
Study 2 found that patients’ conceptual definition of SDM included four components: exchange
of information, active listening, patient-self advocacy, and a personalized physician
recommendation. Patient descriptions of recent decisions labeled as shared ranged from very
simple recommendations through complex interactions, with the only commonality among
shared decisions being that the patient and physician ultimately agreed.
Study 3 found that the most commonly observed component of patient-defined SDM was patient
self-advocacy (76%) and least common was a personalized physician recommendation (23%).
Only 9% visits contained all four patient-defined SDM components. In adjusted models,
physician provision of information around the process and potential side effects of colorectal
cancer screening was associated with an increase in screening. There were differences in
screening rates by the patient’s initial verbal response to the physician recommendation with
those who initially refused being least likely to be screened (40%) and patients who did not
verbalize a response to the recommendation being most likely to be screened (70%).
Discussion: Findings across the three studies highlight the complexity of studying and
measuring SDM and emphasize the importance of the patient’s perspective on SDM.
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Chapter 1: Introduction

In recent years, shared decision making (SDM) has been suggested as an optimal
approach to medical decision making. 1 While relatively new, the literature on SDM is large and
growing, with an increasing emphasis on determining the patient outcomes associated with the
use of SDM. Accordingly, physicians are being encouraged to employ a SDM process with
patients. For example, the National Cancer Institute’s monograph on patient-centered
communication identified decision-making as one of the six core functions of patient centeredcommunication, stating that decision-making should be characterized by active engagement by
both patient and physician. 2 Furthermore, the U.S. Preventive Services Task Force advocates for
physicians to use SDM when making cancer screening and other preventative health
recommendations to patients. 3 Despite the widespread endorsement of SDM, there not a clear
consensus on what SDM actually entails. Furthermore, there is little knowledge of the empirical
evidence of either what it means to the parties involved or its impact on outcomes.
A recent review of SDM literature found that over 61% (257 of 418) of articles provided
no definition of SDM. 4 However, of the articles that provided definitions, that developed by
Charles et al. (1997) was most often cited. Charles et al. (1997) define SDM as having four key
components that all must be present for a decision to be considered shared: (1) at least two
participants (patient and physician) are involved in all phases of the decision-making process; (2)
both parties share information; (3) both parties take steps to build a consensus around the
decision; and (4) agreement is reached. 5 While this definition was cited three times as often as
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any other published definition, 4 there remains some disagreement about the critical components
of SDM. For example, the U.S. Preventive Services Task Force’s definition of SDM does not
require that the patient be involved actively but rather that “the patient has engaged in decisionmaking at a level at which he or she desires and feels comfortable.” 3 Others have suggested that
patient and physician need not reach an agreement to have participated in a SDM process. 4
However, because the Charles et al. (2007) definition is the most commonly used definition, it
will be used in this study as the normative definition of SDM, upon which other perceptions of
SDM will be compared.
Measurement of SDM
In addition to differing definitions of SDM in the literature, there are also many
approaches to measuring SDM in practice. The two most common methods of measuring SDM
are observer ratings (via coding of direct observation or recordings of medical consultations) and
patient self-reports of having participated in SDM. In recent years there have been a variety of
formal coding systems created to measure medical decision-making including the Decision
Analysis System for Oncology scale (DAS-O 6), the Decision Support Analysis Tool (DSAT 7),
the Shared Decision Making Scale, 8 and the OPTION scale. 9 While some of these coding
systems have been found to be moderately correlated with one another, they each focus on
different aspects of SDM and have been validated in separate populations. 10 These differences
represent the continued disagreement within the academic community about what constitutes a
shared decision. Additionally, these coding systems all focus primarily on physician behaviors
and do not specifically take into account patient involvement. 11
The most common way of measuring SDM is through patient self-report. 11 Instruments
that measure patient self-reports of SDM range from single-item scales (e.g. Control Preference
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Scale 12) to multi-item, single dimensional scales (e.g. 9-item Shared Decision making
Questionnaire SDM-Q-9 13; Facilitation of Patient Involvement Scale 14), through multidimensional scales in which SDM is one of many aspects (e.g. Decisional Conflict Scale 15;
Decision Evaluation Scales 16; Perceived Involvement in Care Scale 17; Combined Outcome
Measure for Risk Communication and Treatment Decision-making Effectiveness
(COMRADE) 18). As with observer rating instruments, there is no clear gold standard on how to
measure patient-reports of SDM.
Patient and physician perceptions of SDM
While there are many measurement tools for patient reports of SDM, very few studies
have looked specifically at understanding patient and physician perceptions of SDM. There is
evidence, however, that patients may understand SDM differently than researchers. For
example, a recent study using audio-recordings of routine annual physical examinations found
that researcher-defined SDM (using the Charles et al. (1997) definition 5) was not correlated with
patient reports of SDM. 19 After the exam, patients were asked about their role in the colorectal
cancer screening decision-making and 47% (171 of 363) reported using a SDM process.
However, when the audio-recordings of the visits were coded using Charles et al.’s (1997) model
of SDM, only 0.3% (1 of 363) met the criteria for SDM. Another recent study measured SDM
from three perspectives (patient, physician, and observer) and found that observer ratings of
SDM were completely unrelated to patient or physician ratings, and that patient and physician
perceptions were only moderately correlated. 20 Taken together, these results point to a likely and
substantial discrepancy between patients’ and researchers’ perceptions of SDM.
We know of only two studies that have directly explored the meaning of SDM to
patients; both qualitative studies conducted in the context of diabetes treatment. 21,22 The study
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by Peek and colleagues (2008) looked specifically at the meaning of SDM to African Americans
with diabetes. They found that patients emphasized the importance of being able to “tell their
story and be heard” and reported that information sharing was a vital part of SDM. However, the
patients also suggested that negotiation and sharing of the actual decision were not necessary to
have participated in SDM. 21 The second study by Entwistle and colleagues (2007) used in-depth
interviews to investigate the meaning of involvement in treatment decisions among 18 adults
with diabetes. This study also found that patients felt they were involved in decision-making
when they were able to communicate their views and believe that their physician listened. 22 In
addition, patients reported that the “feel” of the appointment was important and patients were
more likely to report being involved when they perceived that their physician respected them.
The results from these two studies indicate that relational components of SDM may be more
important to patients than current published definitions of SDM indicate, consistent with the
recent finding that patient ratings of physician relational communication are associated with
patient reports of SDM. 19
Patients may also perceive SDM differently than physicians. In a study of women in
treatment for breast cancer, for example, patients and physicians were asked to indicate who
made the treatment decision using a modification of the Degner et al. (1997) Control Preferences
Scale. 12,23 This scale is commonly used in measuring patient perceptions of SDM and asks
patients to rate their role in making a specific decision among 5 choices: (1) I made the final
decision, (2) I made the final decision after seriously considering my doctor’s opinion, (3) My
doctor and I shared the responsibility for deciding, (4) My doctor made the final decision but
seriously considered my opinion, and (5) My doctor made the final decision. Choice 3 is
considered a shared decision. 12 On this scale, only 38% of patients and physicians agreed on
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who made the treatment decision. Moreover, 50% of physicians reported making a shared
decision, while only 30% of patients reported the decision as shared. 23 The poor concordance
between patient and physician reports indicates a discrepancy in how physicians and patients
perceive medical decision making.
Taken together, these studies indicate that there are differences in how patients and
physicians perceive SDM and that the commonly used Charles’ et al. (1997) definition may not
represent the perceptions of either group. Additionally, it is not clear which of these perspectives
are associated with positive patient outcomes. Therefore, richer understanding of how patients
and physicians perceive SDM is required to foster the type of active medical decision making
that meets patients’ expectations and promotes health.
SDM and colorectal cancer screening
The U.S. Preventive Services Task Force (USPSTF), as well as numerous other medical
societies, recommends that adults aged 50 to 75 receive regular colorectal cancer screening.
Although there is general evidence to support the benefits of timely screening, there is less
agreement regarding how patients should be screened. The USPSTF recommends screening via:
(1) a fecal occult blood test every year, (2) a flexible sigmoidoscopy every 5 years, or (3) a
colonoscopy every 10 years. 24 The USPSTF also advises that physicians use a shared decision
making process when recommending colorectal and other preventive services to patients. 3
Despite these recommendations, some 40% of the US population remains unscreened for
colorectal cancer 25 and approximately 50,830 men and women in the United States will die of
colorectal cancer in 2013. 26 The CDC estimates that 60% of colorectal cancer deaths could be
prevented if everyone were screened as recommended. 27
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Known barriers to colorectal cancer screening include a lack of a physician
recommendation for colorectal cancer screening, cost, lack of health care insurance, and
embarrassment or fear over the screening test or preparation for the test. 28 A recent study
surveyed over 3,000 primary care patients and asked them to identify the most significant
obstacle to receiving CRC screening among a list of known barriers. The list included both
generic barriers, or those that apply across screening modalities, and specific barriers for each
type of screening modality. Of the generic barriers, “my healthcare provider never suggested I
get this test” and “I did not know I should have this test” were most often identified as the top
overall barrier to screening. 28 These findings indicate that not having a discussion about the need
for colorectal cancer screening is among the most important barriers to screening, as identified
by primary care patients.
Similarly, another recent study found that although physicians pointed to patient factors,
such as fear of pain and embarrassment about testing, to be important barriers to colorectal
cancer screening, patients eligible for colorectal cancer screening who had never been screened
cited not having a physician recommendation as their most important barrier to screening. 29
While we know that screening use increases with a greater number of primary care visits, and
thus more opportunities for a physician recommendation, 30,31 a simple recommendation or
discussion does not guarantee colorectal cancer screening use. Even among those with a
physician recommendation, some 40% will still go unscreened. 32
The content of the discussion is important as well, with more comprehensive discussions
about colorectal cancer screening being associated with increased screening use. 33 In line with
these findings, patient reports of having participated in SDM are associated with increases in
colorectal cancer screening rates, 34 and a recent randomized controlled intervention trial of the
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behavioral mediators of colorectal cancer screening found that patient-provider communication
about colorectal cancer screening was the most important behavioral mediator for screening
usage. 35
Thus, colorectal cancer screening discussions and decisions have a direct impact on
patient health outcomes, illustrating the need for a better understanding of patient and physician
perceptions of SDM around colorectal cancer screening.
The aims of my research
Patient perceptions of having participated in SDM are associated with a variety of
positive outcomes (e.g. 36,37). However, little is known about what leads patients to perceive and
thus report a decision as shared. As communication and decision-making processes are
amenable to change, there is potential to foster SDM in practice. Yet, without an understanding
of how patients perceive SDM, our ability to foster decision-making processes that are associated
with positive outcomes is hindered. My research is designed to: (1) understand under what
measurement conditions SDM is associated with what types of patient outcomes; (2) provide
insight into how patients perceive SDM; and (3) apply a patient-informed definition of SDM to
the context of colorectal cancer screening and evaluate the relationship between patient-defined
SDM and adherence to physician recommended colorectal cancer screening. With this
knowledge, future research can focus on developing interventions that help patients and their
physicians achieve SDM and its associated benefits in practice.
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Chapter 2: Where is the evidence? A systematic review of shared decision-making and
patient outcomes
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Abstract!

Background: Despite widespread advocacy for shared decision making (SDM), the empirical
evidence regarding its effectiveness to improve patient outcomes has not been systematically
summarized.!
!

Purpose: To systematically review the patient outcomes studied in relation to SDM and identify
under what measurement contexts SDM is associated with which types of patient outcomes.
Data Sources: PubMed (through December 2012) and hand search of article bibliographies.
!

Study Selection: Studies were included if they empirically (1) measured SDM in the context of
a patient-clinician interaction, and (2) evaluated the relationship between SDM and at least one
patient outcome.
Data Extraction: Outcomes were categorized by SDM measurement perspective (patientreported, clinician-reported, or observer-rated) and outcome type (cognitive, behavioral, or
health).
!

Data Synthesis: Thirty-nine studies met inclusion criteria. Thirty-three used patient-reported
SDM, six used observer-rated, and two used clinician-reported SDM. Ninety-seven unique
patient outcomes were assessed; 51% cognitive, 28% behavioral, and 21% health. Only 43% of
assessments (n=42) found a significant and positive relationship between SDM and the patient
outcome. Results varied by SDM measurement perspective and outcome category. 52% of
outcomes assessed with patient-reported SDM were significant and positive, compared to 21%
with observer-rated and 0% with clinician-reported SDM. Regardless of measurement
perspective, cognitive patient outcomes were most likely to be associated with SDM (54%),
compared to 37% of behavioral, and 25% of health outcomes.
!

Conclusions: SDM, when perceived by patients as occurring, seems to improve cognitive
outcomes, such as decisional conflict. Yet, available empirical evidence does not yet support an
unequivocal relationship between SDM and patient behavioral and health outcomes.
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Introduction
Since the early 1980s, shared decision making (SDM) has been suggested as an optimal
approach to making health care decisions. 1,38,39 Both the Institute of Medicine and the U.S.
Preventive Services Task Force have advocated for clinicians to use SDM when making
preventive health and treatment recommendations. 3,40 Most recently, language contained in the
Affordable Care Act specifically calls for programs to facilitate shared decision making and the
establishment of the Patient Centered Outcomes Research Institute. 41 Furthermore, a recent
systematic review of patient decision-making preferences found that the majority of patients
prefer to be actively involved in decision-making and that the trend for a preference for shared
decisions has increased over time. 42
While the concept of SDM is often intertwined with decision aids, there are conceptual
differences in the two. Although there is not universal agreement around a definition of SDM, it
is generally thought to be a process in which a patient and clinician collaborate to make the best
possible medical decision for the patient. 43 Decision aids most often are defined as tools to help
patients to become better informed about the potential benefits and harms of treatment choices,
to weigh the pros and cons based on their unique values and medical characteristics, and to be
prepared to actively participate with their clinician in making a medical decision. 44 Thus, while
both SDM and decision aids have the same end goal of a patient making a well-informed and
value-concordant decision, 44-46 decision aids may or may not employ SDM to reach this end and
SDM can occur outside of the use of a decision aid.
Previous systematic reviews have pointed to the effectiveness of decision aids for
improving patient outcomes, 44 but as evidenced by these reviews, use of a decision aid does not
ensure that SDM occurred. For example, in the most recent Cochrane review of decision aids
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(2011), only 16 of the 86 randomized trials reviewed explicitly measured the effects of decision
aids on patient participation in decision-making. Among these studies, there were no differences
in patient reports of having participated in SDM between those given a decision aid or those
receiving usual care. 44 Thus, the positive effects of decision aids on patient outcomes may not be
attributable to SDM. Moreover, the empirical evidence surrounding SDM is not confined to
studies of decision aids only.
Despite widespread advocacy for SDM and a growing body of literature evaluating its
use, the empirical evidence regarding its effectiveness as a mechanism to improve patient
outcomes has not been systematically summarized. Additionally, SDM has been measured in a
variety of ways across studies, and whether these different measurement perspectives are
differentially associated with patient outcomes is not known. The objectives of this systematic
review are to (1) describe the patient outcomes that have been studied in relation to SDM and (2)
identify under what measurement contexts SDM is associated with which types of patient
outcomes.
Methods
Conceptual Framework
The conceptual framework guiding this systematic review was adapted from models by
Street and colleagues 47 and Kreps and colleagues 48 (Figure 2.1). In their model of pathways in
which clinician-patient communication can lead to better health, Street and colleagues posit that
while communication between clinicians and patients, including SDM, can lead to improved
health outcomes directly, in most cases communication affects health indirectly through
proximal and intermediate outcomes. As proposed by Kreps and colleagues in their
Transformation Model of Communication and Health Outcomes, 48 we change the categorization
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of outcomes from a temporal classification to a conceptual classification. This latter model
asserts that patient outcomes should be categorized by their impact on the individual across three
categories: cognitive, behavioral, and physiological. Cognitive outcomes include knowledge,
attitudinal, and affective/emotional effects. Behavioral outcomes include both adherence to
recommended treatments and adoption of health behaviors. Physiological outcomes (which we
have broadened to label as health outcomes) include quality of life, self-rated health, and
biological measures of health (e.g. blood pressure). 48
!

Adapted from Street et al. (2009) and Kreps et al. (1994)
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Figure 2.1: Conceptual framework linking SDM to patient outcomes.
!

Inclusion and Exclusion Criteria
Studies were included in this review if they empirically (1) measured SDM in the context
of a patient-clinician interaction, and (2) evaluated the relationship between SDM and at least
one patient outcome. Excluded studies were those not in the context of a patient-clinician
interaction, that reported only qualitative data, or that were reviews or commentaries. Also
excluded were studies that evaluated the relationship between SDM and patient outcomes but did
!
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not directly measure SDM. As such, evaluations of decision aids and other interventions which
assumed that use of the decision aid led to a SDM process, but which did not explicitly measure
SDM were excluded.
Search Strategy
We began with the primary search strategy outlined by Makoul and Clayman (2006) in
their systematic review of the SDM literature. 4 Specifically, in January 2013, we conducted a
PubMed search for English-language articles published through December 31, 2012 with the
words shared decision making in the title or abstract. Makoul and Clayman reasoned that this
search strategy captured articles with a clear focus on shared decision making in the medical
literature and that the simple approach allows for reproducibility for future studies. 4 No start
date was specified so that all studies published up through the end of 2012 would be included.
The resulting abstracts were reviewed for inclusion and exclusion criteria. I read and reviewed
the full text of those articles meeting the study inclusion criteria and collected any non-redundant
references to SDM.
Among study eligible articles, patient outcomes were defined as observed or self-reported
effects in association with a specific patient-clinician encounter or overall medical care. Because
a number of eligible studies evaluated more than one patient outcome in relation to SDM, the
unit of analysis for this review is a patient outcome.
Classification framework
There are multiple ways that SDM can be measured. 4,11 A priori we expected the
measurement of SDM to fall into two primary categories: patient self-reports of SDM or
observer-ratings of the use of SDM (usually via structured coding of audio-recordings). Our
review of the literature also revealed a third category: clinician reports of using SDM with
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patients. In addition to considering the SDM measurement perspective, as indicated in the
conceptual framework (Figure 2.1) we also considered the type of outcome evaluated using the
three classifications proposed in the Transformation Model of Communication and Health
Outcomes 48: cognitive, behavioral, or health outcome. Combined, these categorizations resulted
in a 3 x 3 classification framework that was used to structure the results of the systematic review
(Figure 2.2).
SDM
Measurement
Perspective

Patient Outcome Category
Cognitive

Behavioral

Health

Patient selfreported
Clinician selfreported
Observer
rated

!

Figure 2.2: Categorization framework of patient outcome categories by SDM measurement
type

Assessment of the quality of studies
We used a modified version of the Systematic Appraisal of Quality in Observational
Research (SAQOR) tool to assess the quality of included studies. 49 SAQOR was created for use
in systematic reviews to assess the quality of observational studies. Each study was rated as
adequate, inadequate, or unclear across six categories: sample, research design, quality of
measures, follow-up, distorting influences (confounders), and reporting of data. A total score for
each study is computed by counting the number of categories marked adequate. Thus the total
quality score has a range of 0 to 6, with higher scores indicating higher quality studies. Total
!

$'!

!

scores of 5 or 6 represent high quality, scores of 3 or 4 represent moderate quality, and 0 to 2
represent low quality observational studies. 50
Results
Overview of studies
Forty-one publications, 10,17,51-89 representing 39 unique studies, met the inclusion criteria
(Figure 2.3; Table 2.1 on page 26). Thirty-four of the 41 articles meeting inclusion criteria were
published in the last ten years and the earliest study meeting the inclusion criteria was published
in 1989.51
The 39 studies were conducted across a variety of clinical contexts. Fourteen studies
(36%) were conducted in the context of cancer care, and almost three-quarters of these (n=10)
focused specifically on breast cancer treatment and surgery decisions. Other clinical contexts
studied included mental health (n=5), diabetes (n=5), serious injury (n=3), heart disease (n=2),
HIV (n=2), and general primary care (n=2) among others (n=6).
!"#$%&!"#$%!&$#'()*+,-*)'$.%/01.'20"3*)'#*!%&.'!+)'#&%**+*)'4/%'
(+&50#(/+'
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''HIJ'+/$'(+'$.*'&/+$*8$'/4'!'>!,*+$7&5(+(&(!+'%*5!,/+#.(>'
''CKC':;3'+/$'=*!#0%*)'/%'=/)*5*)'<($.'>!,*+$'/0$&/=*#'
#'(&60557$*8$'!%,&5*#'!##*##*)'4/%'*5(1("(5($9'
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Figure 2.3: Search strategy and selection results
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Quality assessment
The SAQOR quality scores ranged from 2 to 6, with a median score of 3 (Table 2.1).
Across the 39 studies, six (15%) received a high quality rating, 25 (64%) moderate, and eight
(21%) low. Most of the studies were either cross-sectional or prospective surveys in which data
were collected either before and after, or only after, a consultation with a clinician. Nine of the
39 studies were conducted in the context of a clinical trial. 53,58,64,65,68,70,72,77,82 Eight of these were
a secondary analysis of a previous RCT. 53,58,64,72,77,82 In these studies, the analysis either was
conducted without regard to group assignment, 77,82 group assignment was used as a predictor
variable in the model, 58,64,68,72 or the results were tested separately to see if group assignment
confounded the relationship between measured SDM and patient outcomes. 53,65 The ninth study
included a patient self-report of participation in SDM, but only tested the association of patientreported SDM with a patient outcome among those in the experimental group. 70 Thus, none of
the included RCTs evaluated the association between SDM and a patient outcome with a
randomized design.
SDM Measurement Perspective
Eighty-five percent of studies measured SDM from the patient’s perspective (n=33), 15%
(n=6) via observer rating, and two (8%) used clinician-reports to measure SDM. In two
studies,74,81 the same patient outcome was assessed for its association with SDM from different
SDM measurement perspectives and these analyses are considered separately.
Patient-reported SDM was measured in a variety of ways across studies. The most
commonly used measure was a modified version of the Control Preference Scale 12 in which
patients rate their perceptions about their level of involvement in decision-making (n=13
studies). The second mostly commonly used patient-reported measure of SDM was the multi-
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item Patient Involvement in Care Scale, 17 which was used in four studies. A variety of other
single and multi-item measures of SDM were used (n=16 studies).
Five of the six studies that included observer ratings of SDM used the OPTION scale in
which observers rate the communication between patient and clinician on 12 items. 90 The
OPTION scale is either completed by an in-person observer in real time or is used to rate audiorecordings of patient/clinician interactions.
Clinician-reported SDM was used in two studies, both in the context of diabetes. 81,84 One
of these used a modified version of the Control Preference Scale 12 and the other used a 9-item
Self-Assessment Questionnaire. 91
Patient Outcomes Evaluated
The number of patient outcomes evaluated per study ranged from 1 to 7 with a total of 95
unique patient outcomes and 97 unique patient outcome-SDM measurement pairs assessed
across the 39 studies (Table 2.2). Among the 97 outcome assessments, 51% (n=50) were
cognitive, 28% (n=27) behavioral, and 21% (n=20) health outcomes. Half of the cognitive
variables studied were around patient satisfaction (n=25). Beyond satisfaction, cognitive
variables included concerns/anxieties about the illness (n=5), decisional conflict (n=4), anxiety
following the consultation (n=4), confidence in the decision (n=2), and knowledge (n=2) among
others. The most frequent behavioral variable assessed was around the treatment decision itself
(n=10), with nine of these regarding breast cancer treatment decisions. Other behavioral
variables include treatment/medication adherence (n=7), health behaviors (n=3), and others.
Health outcomes included patient ratings of overall health (n=6) and quality life (n=3),
depressive symptoms (n=5) and other patient-reported measures (n=2), as well as a blood
pressure (n=2) and other physiological measures (n=2).
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Table 2.2: Patient outcomes assessed by SDM measurement perspective and outcome
category (n=97)
SDM
Measurement
Category

Patient Outcome Category
Cognitive
(n=50)

Patientreported
SDM

Clinicianreported
SDM
Observerrated
SDM

Behavioral
(n=27)

Health
(n=20)

Satisfaction with care (x7)
Concern/anxiety about illness (x5)
Satisfaction with decision (x5)
Decisional Conflict (x3)
Satisfaction with consultation (x3)
Anxiety after consultation (x2)
Control over medical problem (x2)
Health care empowerment (x2)
Knowledge (x2)
Satisfaction with information received (x2)
Trust in physician (x2)
Confidence in decision
Predicted discomfort
Predicted functional capacity

Decision about breast cancer treatment (x7)
Medication/treatment adherence (x6)
Diet
Disclosure of CAM use
Exercise
Number of treatment strategies agreed upon
Receipt of depression care
Stress management behaviors
Use of CAM

Pt rated health/symptoms (x6)
Depressive symptoms (x5)
Quality of life (x3)
Anxiety
Blood pressure
Emotional functioning

Satisfaction with provider communication

Medication adherence
Receipt of dilated eye exam
Receipt of hemoglobin A1c assessment
Receipt of lipid assessment

Blood pressure
Hemoglobin A1c
Lipid level

Satisfaction with decision (x 4)
Anxiety immediately after consultation (x 2)
Satisfaction with consultation (x 2)
Confidence in decision
Decisional conflict
Satisfaction with physician's SDM skills

Decision about breast cancer treatment (x 2)
Decision about treatment for arrhythmia

Associations between SDM and patient outcomes
As can be seen in Table 2.3, less than half (n=42; 43%) of assessments found a
statistically significant and positive relationship between SDM and the patient outcome. Results
varied by both the SDM measurement perspective and the category of patient outcome. When
SDM was measured from the perspective of the patient, regardless of the outcome category,
assessments were more likely to result in significant associations. Across all outcomes assessed,
52% were significantly and positively associated with patient-reported SDM, compared to only
21% of outcomes when SDM was observer-rated and 0% when SDM was clinician-reported.
Similarly, regardless of how SDM was measured, cognitive patient outcomes were most likely to
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be associated with SDM. Fifty-four percent of cognitive outcomes were positively associated
with SDM, compared to 37% of behavioral, and 25% of health patient outcomes.
Three studies found negative effects of SDM on patient outcomes including an increase
in decisional conflict, 58 a decrease in patient satisfaction, 63 and an increase in patient reports of
the impact of breast cancer on their life. 67 All three were cognitive patient outcomes in the
context of patient self-reports of SDM.
Table 2.3: Summary of results by SDM measurement perspective and patient outcome
category
SDM
Measurement
Perspective

Patient Outcome Category
Cognitive

Behavioral
n

Patient
reported

25

66% Positive

NS*

10

26% NS

Total measured

38

8% Negative
Total measured

0% Positive

11
0

45% Positive
55% NS
0% Negative

20

Total measured

NS

1 100% NS

4 100% NS

Negative

0

0

Total measured

1

0% Negative
Total measured

0

0% Positive
0% Negative

4

Total
n

0

Total measured

5
12
0

%

n

%

29% Positive

39

52%

71% NS

33

44%

3

4%

0% Negative

17

0

Total measured

0% Positive

0%

3 100% NS

8

100%

0

0

0%

0% Negative

3

Total measured

8
3

21%

11

79%

0

0%

18% Positive

1

33% Positive

0

--

Positive

NS

9

82% NS

2

67% NS

0

--

NS

Negative

0

0

--

Negative

0% Negative

0% Negative

Total measured

11

Positive

27

54% Positive

10

37% Positive

NS

20

40% NS

17

63% NS

Total measured

•

3
50

Total measured

0

6% Negative
Total measured

3

0

Total measured

0% Negative

27

Total measured

75

0

2

Negative

!

3

9

%

Positive

Observer rated Positive

Total

n

Positive*
Negative*

Clinician
reported

%

Health

0
5
15
0
20

Total measured

14

25% Positive

42

43%

75% NS

52

54%

3

3%

0% Negative
Total measured

97

Positive refers to a significant, positive (i.e. beneficial) association between SDM and the patient
outcome. NS refers to a non-significant association. Negative refers to a significant, negative
(i.e. non-beneficial) association between SDM and the patient outcome
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five health outcomes that were found to be associated with SDM were patient self-reported
outcomes, including a one-item ratings of general health rating,72 discomfort,51 symptom
improvement, 51 general medical improvement, 51 and measure of depressive symptoms rated on
the Center for Epidemiologic Studies-Depression scale. 65 Among these, only depressive
symptoms were measured using a multi-item, previously validated scale. 65 None of the four
physiological measures assessed were associated with SDM. 70,84
Discussion
Relatively few empirical evaluations have been conducted between SDM and patient
outcomes. We found a total of 39 unique studies, which included 97 assessments of the
relationship between an empirical measure of SDM in the context of a patient-clinician
interaction and a subsequent patient outcome. Cognitive outcomes were assessed most often and
were primarily patient reports of satisfaction, decisional conflict, or other perceptions
immediately after an interaction with a clinician. Furthermore, relative to behavioral and health
outcomes, cognitive outcomes were most often found to be significantly and positively
associated with SDM. While cognitive outcomes are important and represent SDM’s origins as
an ethical call to increase patient autonomy, 39,92 there has been a shift towards understanding
how patient-clinician communication, including SDM, may be associated with more distal
behavioral and health outcomes. 2,47,93
Although there are strong ethical and interpersonal reasons to advocate for SDM, our
findings illustrate the continued uncertainty surrounding SDM as a mechanism to improve
patient outcomes. Regardless of the type of patient outcome considered or the SDM
measurement employed, empirical evaluations more often than not have found no positive and
statistically significant relationship between SDM and a patient outcome. The one exception is
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among assessments that evaluated a cognitive patient outcome in relation to patient-reported
SDM. Within these assessments, the majority (66%) found a significant and positive
relationship between SDM and a subsequent patient outcome. Notably lacking were any studies
that evaluated the association between observer-rated SDM and patient health outcomes.
Clinician reports of SDM were also rare, with the eight such associations evaluated here coming
from only two independent studies, with none found to have a significant association with a
patient outcome.
Results from this review indicate that the link between SDM and health patient outcomes,
in particular, has yet to be fully established. Our review highlights several important points
regarding the assessment of SDM and patient health outcomes. First, health outcomes were least
studied. Second, when health outcomes have been assessed in relation to SDM, the outcomes
have most often been measured via patient self-report, and often with un-validated instruments.
In total, only five of the 20 (25%) health outcomes evaluated were found to be associated with
SDM, and four of these used single-item un-validated measures. Furthermore, we identified only
four physiological measures of patient health (blood pressure, hemoglobin A1C, and lipid level)
that have been evaluated for their association with SDM, and none of these evaluations identified
a statistically significant relationship. 70,84 Despite the fact that conceptual models of patientclinician communication hypothesize that communication is most likely to have an indirect effect
on patient health outcomes, the studies included here tested only for a direct effect of SDM on
health outcomes. Without mediation or path analysis models designed to specifically examine
indirect effects, the relationship between SDM and patient health outcomes is likely to remain
elusive.
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As previously reported, 4,11 within the patient-perceived SDM measurement category a
wide range of measures of patient perceptions of SDM are currently being used. While
variations of the Control Preference Scale 12 are most commonly used, we found 16 different
instruments used across the 33 studies that measured SDM via patient self-report. Whether the
Control Preference Scale or some other instrument is used to capture patient-reported use of
SDM, more often than not, items contained in these instruments do not enable an understanding
of what it is about the decision-making process that leads a patient to report that it was shared.
This is particularly troubling as several recent studies have found that observer ratings of SDM
do not predict patient reports of having participated in a shared decision. 19,74,94 These results,
combined with our findings that when positively associated with a patient outcome it is patientperceived SDM, and not observer-rated SDM that is important, only serve to highlight the
challenge and need to understand what leads a patient to label a decision as “shared.” Without
such an understanding, our ability to foster SDM processes in practice will continue to be
hindered as will our ability to fully understand the impact of SDM on patient outcomes.
Notably lacking among the SDM literature are randomized trials evaluating the impact of
a communication/decision-making intervention on patient outcomes that empirically measure the
communication/decision-making process used. There have been many RCTs in recent years that
have evaluated the effects of some type of communication or decision-making intervention on
patient outcomes. These interventions most often center on a decision aid, but also include
patient or clinician communication training interventions. 95,96 These studies have rarely included
an empirical measure of SDM, instead assuming SDM to have occurred based upon group
assignment. Our review identified only 9 studies conducted in the context of a randomized
trial,53,58,64,65,68,70,72,77,82 and despite the design of the parent study, none evaluated the association

!

%%!

!

of SDM and a patient outcome in the context of the randomized design. To compliment
thoughtful conceptual models that hypothesize the paths between patient and clinician
communication behaviors and patient outcomes (e.g.47), well designed studies are needed that
formally test whether decision-making and communication interventions lead to increase SDM,
and then whether it is these increases in SDM (or something else) that are associated with health
outcomes. SDM may mediate, or even moderate the relationship between communication or
decision-making interventions and patient outcomes, but as of yet these relationships remain
untested in the empirical literature.
Limitations
Our conceptual framework examines impact of SDM on patient outcomes across two
important domains – the way in which SDM was measured and the category of patient outcome.
However, there are undoubtedly other dimensions that are important to understanding the
relationship between SDM and patient outcomes. For example, the clinical context in which the
decision was made and the nature of the decision itself (prevention vs. acute treatment vs.
chronic treatment decisions, etc.) may influence the impact of SDM on patient outcomes. Given
the relatively small number of studies identified as eligible for study inclusion, we were not able
to further categorize studies for this first systematic review.
We recognize that SDM (particularly patient perceptions of SDM) may not be limited to
the context of one visit between a patient and clinician, but rather patient reports of SDM may be
influenced by the prior relationship between the patient and clinician or by the influence of other
parties in the decision. 19 This is especially likely to be true in primary care and chronic disease
contexts in which patients and their clinicians often make multiple decisions over the course of
many visits. However, none of the studies identified here measured SDM across a long-standing
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relationship, and thus we are unable to discuss how SDM may affect patient outcomes over time.
Additionally, all of the studies reviewed here examined SDM in the context of a patient and
clinician only, limiting our ability to examine the effects of having family members or others
participate in decision-making.
Furthermore, the results and conclusions presented here may be influenced by publication
biases. Although we were careful to review articles identified as eligible for inclusion for
additional non-redundant references, we did not attempt to identify and include results from unpublished studies. Additionally, due to the diversity of patient outcomes assessed across studies
we were not able to use meta-analysis methods. As consensus is built around the measurement
of SDM and the patient outcomes most salient to SDM, future systematic reviews may be able to
use a meta-analysis to formally combine and assess the evidence across studies.
Conclusion
Our review suggests that when patients report that they have participated in shared
decision making, they are likely to enjoy better cognitive outcomes, such as improved
satisfaction and less decisional conflict. Furthermore, patient reports are the only SDM
measurement perspective found to be associated with patient health outcomes, albeit in a
minority of those studies. The challenge with these findings is that we do not know what leads a
patient to report a decision as shared, and thus do not know how to foster SDM and its associated
benefits in practice. Thus, not only should future studies continue to address the impact of SDM
across a continuum of patient outcomes and clinical settings, they should also address the
methodological challenges associated with such evaluations. Patients increasingly report a desire
to engage in shared decision making, and SDM remains an important tool to promote patient
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autonomy and satisfaction. However, our findings indicate that the link between SDM and
patient behavioral and health outcomes has yet to be fully established.
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Table 2.1: Summary of included studies by SDM measurement perspective

First Author

Year

Diseases
context

n

Design

SDM
Measurement

Patient outcomes
measured

Summary of results
SDM associated with:
(unless noted the association
was significant in the expected
direction in a multivariate
model)

(patient;
provider
if
reported)

Quality
rating
SAQOR
score
and
rating

Patient selfreported SDM

Brody

Lerman

Chambers

!

1989

1990

1999

Primary
care,
various

Primary
care,
various

Asthma
(primary
care)

117

83

394

Cross-sectional
survey after primary
care visit

13-item
Perceived
Involvement in
Care Scale
(PICS)

Sense of personal
control; concern
regarding illness;
satisfaction with the
physician; expediting
discomfort;
experiencing
dysfunction; symptom
improvement; general
medical improvement.
Satisfaction with the
art of care; satisfaction
with the technical
aspects of care;
understanding about
illness; reassurance
regarding health
status; perceived
control over medical
problem; predicted
discomfort; predicted
functional capacity

Cross-sectional
survey, SDM
questions are not
about one specific
interaction

1-item variant of
CPS

Regular use of inhaled
corticosteroids

Survey at baseline, 1
day, and 1 week postconsultation

1-item variant of
Control
Preference
Scale (CPS)

"#!

SDM associated with greater
sense of personal control, lower
post-visit levels of concern
regarding illness, less discomfort,
greater symptom improvement
and greater improvements in
overall medical condition one
week after visit.
No association between SDM and
experiencing dysfunction one
week after visit.

4
Moderate

SDM associated with satisfaction
with the technical aspects of care,
understanding about illness,
reassurance regarding health
status, perceived control over
medical problem, and predicted
functional capacity.
No association between SDM and
satisfaction with the art of care or
predicted discomfort.

SDM associated with regular use
of inhaled corticosteroids as
prescribed.

3
Moderate

3
Moderate

!

Gattellari

Golin

Heisler

Keating

!

2001

2002

2002

2002

Cancer,
various

Diabetes

Diabetes

Breast
cancer

233; 9

198

1431

1081

Audio-recorded
consultation and
surveys at baseline,
immediately after
consultation, 1 week,
and 2 weeks postconsultation

1-item variant of
CPS

Face-to-face
interviews before and
after consultation

9-item
Facilitation of
Patient
Involvement in
Care Scale
(FPI)

Cross-sectional
mailed survey

Cross-sectional
phone survey

Anxiety immediately
after the consultation;
anxiety 2 weeks after
the consultation;
satisfaction with the
consultation;
satisfaction with the
information and
emotional support
received; recall of
information.

SDM associated with satisfaction
with the consultation and
satisfaction with the information
and emotional support received.
No association between SDM and
anxiety at either time point or
recall of information.

High

SDM associated with satisfaction
with the visit.
Satisfaction with the
visit

In a subgroup analysis, this
association was found to be true
only for women.

4-item Provider
Participatory
DecisionMaking Style
Scale
(PDMstyle)

Patient-reported
diabetes selfmanagement

In separate multivariate analyses,
both components of SDM are
positively associated with patientreported diabetes selfmanagement. When both
components of SDM are included
in one model , only information
giving remains significant.

1-item rating of
decision making
role developed
for this study

Satisfaction with
treatment information
provided; satisfaction
with treatment choice;
receipt of breast
conserving surgery
(versus mastectomy)

"$!

6

4
Moderate

3
Moderate

SDM associated with satisfaction
with the amount of treatment
information provided.
There was no association
between SDM and satisfaction
with treatment choice or receipt of
breast conserving surgery.

3
Moderate

!
No association in multivariate
analysis.

Heisler

Legare

Ananian

Lantz
(Also Katz
2005; Bleicher
2008)*

!

2003

2003

2004

2005

Diabetes

Menopause

Breast
cancer

Breast
cancer

127; 50

167

181

1633

Cross-sectional
survey of patient and
physician
Cross-sectional
survey of both the
patient and physician
immediately after
consultation

Cross-sectional
survey after decision
before surgery

Cross-sectional
mailed survey study
on average 7 months
after diagnosis

1-item variant of
CPS

1-item variant of
CPS

1-item variant of
CPS

1-item variant of
CPS
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Number of treatment
strategies agreed upon
by patient and provider
Difference between
physician and patient
decisional conflict
Decision about surgery
(mastectomy alone or
mastectomy with
reconstruction);
Decision about timing
of reconstruction
among those receiving
mastectomy with
breast reconstruction
(immediate or delayed
reconstruction)

Satisfaction with
surgery received;
satisfaction with
decision process;
decisional conflict;
decision about surgery
(mastectomy or breast
conserving surgery)

In a bivariate analysis, SDM is
positively associated with the
number of treatment strategies
agreed upon by the patient and
provider. After multivariate
adjustment, the association was
no longer significant.
SDM associated with the
physician experiencing greater
decisional conflict that then patient
(unexpected direction).

4
Moderate
3
Moderate

No associations in multivariate
analysis.
In bivariate analysis, SDM
associated with choice of having
breast reconstruction .

2
Low

SDM associated with greater
satisfaction with surgery received,
greater satisfaction with the
decision process, and less
decisional regret.
Patients who reported SDM were
more likely to receive
mastectomy. In a subgroup
analysis, this association was only
supported for white women and
not for racial groups (Katz).

4
Moderate

!

Nekhlyudov

Thapar

Clever†

Loh

Mandelblatt

!

2005

2005

2006

2006

2006

Breast
cancer

Epilepsy

Depression
(primary
care)

Depression
(primary
care)

Breast
cancer

Cross-sectional
mailed survey study

1-item variant of
CPS

Satisfaction with
decision 6 months
after surgery; current
satisfaction with
decision; current
breast cancer concern;
current depressive
symptoms

975; 115

Cross-sectional
survey study;
Secondary analysis of
RCT

Not described
beyond "patientrated shared
decision
making"

Satisfaction with
physician care of
epilepsy

1706

Survey at baseline, 6,
18, and 24 months
post-consultation;
Secondary analysis of
4 RCTs combined

1-item rating of
involvement in
decision making
developed for
this study

Receipt of guideline
concordant depression
care (antidepressant
medication or
counseling);
depressive symptoms

Longitudinal survey
study - data collected
at initial consultation
and 6-8 weeks later

6-item patient
participation
scale first used
by Mah-SonHing et al. 1999

Depressive symptoms;
treatment adherence

4-item subscale
of PICS

Decision about surgery
(mastectomy or breast
conserving surgery);
receipt of adjuvant
therapy; satisfaction
with care; impact of
breast cancer on life

431

207; 30

718

Cross-sectional inperson survey
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SDM (versus patient-controlled
decisions) associated with lower
satisfaction 6 months after surgery
and lower current concern about
breast cancer.
No associations between SDM
and current satisfaction or current
depressive symptoms.

4
Moderate

3
SDM associated with satisfaction
with physician epilepsy care.

SDM associated with receipt of
guideline concordant depression
care and resolution of major
depression symptoms over 18
months of follow up.
SDM associated with treatment
adherence.
No direct association between
SDM and depressive symptoms,
but there was an indirect effect of
SDM on depressive symptoms
through treatment adherence.
SDM associated with adjuvant
treatment use, satisfaction with
care, and with impact of breast
cancer on life (unexpected
direction).

Moderate

6
High

4
Moderate

In a subgroup analysis, SDM only
associated with adjuvant
treatment use among women
aged 67 to 74, and not among
those aged 75 and older.
4
No association between SDM and
decision about type of surgery.

Moderate

!

Swanson†

Mahone

Deinzer

Hawley

!

2007

2008

2009

2009

Depression
(primary
care)

Serious
mental
illness

Hypertensi
on (primary
care)

Breast
cancer

1317

85

86; 15

1651

Survey at baseline, 6,
18, and 24 months
post-consultation;
Secondary analysis of
4 RCTs combined

3-item rating of
involvement in
SDM developed
for this study

Satisfaction with care

Cross-sectional
survey; Secondary
analysis of 4 RCTs

1-item variant of
CPS

Medication adherence
in the past one month;
medication adherence
in the past 6 months;
quality of life

Prospective
controlled clinical trial

Combined
Outcome
Measure for
Risk
Communication
and Treatment
Decision
Making
Effectiveness
scale
(COMRADE)

Cross-sectional
mailed survey

1-item variant of
CPS

'(!

5
SDM associated with satisfaction
with care.

High

3
No associations.

Moderate

No association.

Blood pressure
(diastolic and systolic)

Receipt of mastectomy
as the initial surgery
treatment

In a subgroup analysis, patients
with a high interest in participating
in SDM who reported an increase
in SDM had a decrease in
diastolic and systolic blood
pressure.
No association between SDM and
rates of mastectomy as the initial
surgery in multivariate model.
In bivariate analysis, women who
reported SDM were less likely to
receive mastectomy initially than
those who reported a patientbased decision.

3
Moderate

4
Moderate
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Janssen

van den
Bergh

Burton ‡

Ommen

Glass

Johnson§

Johnson§

Lim

!

2009

Serious
injury,
various

2009

Prostate
cancer

2010

Heart
disease

2011

Injury or
illness
requiring
hospitalizati
on, various

2012

2012

Various

HIV

2012

HIV

2012

Breast
cancer

90

129

85

2197

Cross-sectional
survey

Cross-sectional
mailed survey study
Surveyed before and
after consultation.
Med students
observed interaction
and coded using
OPTION scale
Secondary analysis of
a cross-sectional,
retrospective mailed
survey study

4-item scale
measuring SDM
as part of the
larger ColognePatientQuestionnaire
(CPQ)

Self-rated health:
"Would you say your
health in general is
excellent, very good,
good, fair, or poor?"

1-item rating of
involvement in
decision making
developed for
this study

Decisional conflict;
depressive symptoms;
generic anxiety;
prostate cancer
specific anxiety

No association between SDM and
depressive symptoms, generic
anxiety, or prostate cancer
specific anxiety.

13-item PICS

Confidence in the
decision

SDM associated with confidence
in decision.

4-item scale
measuring SDM
as part of the
larger CPQ

Trust in physician

SDM associated with trust in
physician.

9-item SDM-Q-9
scale

Satisfaction with
decision

SDM associated with satisfaction
with the decision.

1-item variant of
CPS

Health care
empowerment

SDM is positively associated with
health care empowerment.

Moderate

5
High

2
Low

3

254

Secondary analysis of
a cross-sectional
survey study
Cross-sectional
analysis from a
longitudinal cohort
study

148

Cross-sectional
analysis of a larger
RCT

1-item variant of
CPS

Health care
empowerment

206

Secondary analysis of
a cross-sectional
survey

1-item variant of
CPS

Exercise, diet, stress
management
behaviors

499

4
SDM associated with better selfrelated health.
SDM associated with decreased
decision conflict.

Moderate
4
Moderate
2
Low
2
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No association.
SDM is positively associated with
engagement in exercise.

Low
2

No association between SDM and
diet or stress management.

Low
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Mo

Schleife

Schoenthaler‡

Thum

Wallen

2012

Terminal
cancer

2012

Breast
cancer

2012

Diabetes

2012

Serious
injury,
various

2012

Rheumatic
disease

93

Cross-sectional
survey

107

Cross-sectional
survey

608;41

91

109

Cross-sectional
mailed survey of
patients and
physicians and review
of electronic health
record
Cross-sectional
analysis of a larger
RCT

Cross-sectional
survey study

2-item rating of
involvement in
decision making
developed for
this study
1-item rating of
involvement in
decision making
developed for
this study

13-item PICS
3-item scale
measuring SDM
as part of the
larger CPQ
3-item rating of
involvement in
SDM as part of
the larger
Complementary
and Alternative
Medicine Use in
Arthritis (ICAMP)
questionnaire

Clinician selfreported SDM

!
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Physical functioning;
emotional functioning;
quality of life; quality of
death
Anxiety and
depression; quality of
life

3
No associations.

Moderate
3

No associations.
No association.

Medication adherence

In an additional analysis there was
a significant interaction effect
between social support and SDM
so that the association between
patient perceptions of SDM and
medication adherence was
stronger as social support
increased.

Trust in physician

SDM associated with trust in
physician.

Use of complementary
and alternative
medicine (CAM);
disclosure of use of
CAM to provider

SDM associated with use of CAM
and disclosure of use of CAM to
provider.

Moderate

4
Moderate
3
Moderate

2
Low

!

Heisler

Schoenthaler‡

2009

2012

Diabetes

Diabetes

4198;
1217

608;41

Cross-sectional
mailed survey and
medical record review
Cross-sectional
mailed survey of
patients and
physicians and review
of electronic health
record

1-item variant of
CPS

Satisfaction with
provider
communication; receipt
of dilated eye exams;
assessment of A1c;
assessment of lipids;
elevated A1c; elevated
lipids; elevated systolic
blood pressure

9-item SelfAssessment
Questionnaire

Medication adherence

OPTION scale
(codes for 12
physician
communication
behaviors),
consultation
was audio
recorded and
coded

Satisfaction with
involvement in
decision

4
No associations.

Moderate

4
No association.

Moderate

Observer
rated SDM

Goossensen

Burton‡

Singh

!

2007

Mental
Illness

2010

Heart
disease

2010

Cancer,
various

85

Audio-recorded visits
with post-consultation
surveys
Surveyed before and
after consultation.
Med students
observed interaction
and coded using
OPTION scale

63

Audio-recorded visits
with pre- and postconsultation surveys

61;8

OPTION scale,
consultation
was observed
and coded
Coding system
containing 20
physician
communication
behaviors
developed for
this study

''!

2
No association.

Low

2
Confidence in the
decision

No association.

Low

5
Satisfaction with
consultation; anxiety

No associations.

High

!

Politi

Smith
(Also Butow
2010)

Langseth

2011

2011

2012

Breast
surgery both
prevention
and cancer
treatment

Breast
cancer

Heart
disease

57

Patient visits were
observed and rated
on the OPTION scale,
patients completed 2
surveys (immediately
after consultation and
1-2 weeks late via
phone)

OPTION scale,
consultation
was observed
and coded

55

Audio-recorded visits
with pre-consultation
surveys and then
follow up mailed
surveys at 2 weeks
and 4 months postconsultation

OPTION scale,
consultation
was audio
recorded and
coded

1. Decision
satisfaction; treatment
decision consistent
with recommendation
from physician;
aggressiveness of
treatment chosen
Post-consultation
anxiety; decisional
conflict; satisfaction
with the consultation;
satisfaction with the
physician's SDM skills;
satisfaction with
decision (after 2
weeks); satisfaction
with the decision (after
4 months)

Audio-recorded visits
with post-consultation
surveys

OPTION scale,
consultation
was audio
recorded and
coded

Treatment decision
(invasive or noninvasive)

49; 2

3
No associations.
SDM positively associated with
satisfaction with the decision after
4 months and satisfaction with the
physician's SDM skills.
No association between SDM and
post-consultation anxiety,
decisional conflict, satisfaction
with the consultation, or
satisfaction with decision after 2
weeks.

Moderate

5
High

2
SDM associated with choice of
non-invasive treatment.

Low

* In two cases, the results from one study were published separately in two articles, but the patient outcomes evaluated as well as the measurement of SDM
used overlapped entirely [Butow and Smith; Bleicher and Katz]. The results for each of these pairs of publications are considered only once in the context
of this review.
† Two publications [Clever and Swanson] are secondary analyses of the same sample, but use different measures of SDM modeled with different
outcomes. Each unique SDM measurement and patient outcome assessment is listed separately here and throughout the review.
‡ Two studies measured SDM from multiple perspectives. Each unique SDM measurement and patient outcome assessment is listed separately here and
throughout the review.
§ Johnson et al., 2012 report the results from two separate studies in one publication. Each study is listed separately here and throughout the review.
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Chapter 3: The complexities of understanding patient perceptions of shared decision
making
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Abstract

Introduction: Shared decision making (SDM) has been advocated as an optimal approach to
making health care decisions, both on ethical grounds and increasingly as a means to improve
patient outcomes. However it is not clear how patients perceive SDM and what leads patients to
label a decision as shared.
Methods: In-depth, qualitative interviews were conducted with 23 patients who recently
attended a non-follow up primary care appointment. Patients were asked about the meaning of
SDM and about specific recent decisions that they labeled as shared. Interviews were coded
using a qualitative content analysis approach.
Results: Patients’ conceptual definition of SDM included four components of an interactive
exchange prior to making the decision: both doctor and patient share information, both actively
listen to one another, patients advocate for themselves, and physicians make personalized
recommendations. Additionally, a long-term trusting relationship helps to foster SDM. In
contrast, when asked about why a specific, recent SDM was labeled as shared patients described
interactions that ranged from very simple recommendations through complex interactions.
Common among all decisions labeled as shared was that the patient and physician ultimately
agreed on the decision.
Conclusions: It seems there is no one-size-fits all process that leads patients to perceive a
decision as being shared. Rather, the outcome of “agreement” may be more important than the
actual decision making process used to reach that agreement when patients label a recent
decision as shared.
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Introduction
Increasingly, clinicians are being encouraged to employ a shared decision making (SDM)
process with patients. Both the National Cancer Institute and the U.S. Preventive Services Task
Force, among other organizations, have advocated for the use of SDM. 2,3 SDM has been
suggested as an optimal approach to making health care decisions, 1 first on ethical grounds and
increasingly as a means to improve patient outcomes. 97-99
Despite this increasing attention, what exactly constitutes a shared decision making
process is not always clear. Among the academic literature, the most commonly cited definition
of SDM is that developed by Charles and colleagues. 4,5 This definition includes four key
characteristics, all of which must be present for a decision-making process to be labeled shared:
at least two participants (patient and physician) are involved in all phases; both parties share
information; both parties express treatment preferences; and agreement is reached. 5,100 But there
are a variety of ways that SDM has been measured, including patient self-reports of having
participated in SDM, physician self-reports, and structured coding of patient-physician
communication. 11,101 Among these, only patient-self reports of SDM have been consistently
associated with patient outcomes, including greater patient satisfaction, less decisional conflict,
and medication adherence. 101
Across studies, the most common way of measuring patient perceptions of SDM is using
a modification of the Degner et al. (1997) Control Preferences Scale. 12,101 This scale asks
patients to rate their role in making a specific decision among five choices: (1) I made the final
decision, (2) I made the final decision after seriously considering my doctor’s opinion, (3) My
doctor and I shared the responsibility for deciding, (4) My doctor made the final decision but
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seriously considered my opinion, and (5) My doctor made the final decision. Option 3 is
typically considered a shared decision, and has been associated with patient outcomes including
symptom improvement in primary care patients, 51 medication adherence, 52 and satisfaction with
the consultation, 37 among others. The single-item instrument for ascertaining patient
perceptions of SDM leaves the process in a black box without out a clear understanding of what
SDM means to patients.
Furthermore, studies have repeatedly found that patient perceptions of shared decisions
differ from both observer ratings of SDM, 19,94,102,103 and physician perceptions of SDM. 23,104
Thus in order to attain the benefits of SDM in practice, a greater understanding of the patient
perspective on SDM is needed. We know of only two studies that have directly explored the
meaning of SDM to patients. 21,22 While these studies highlighted important differences between
patient perceptions of shared decision making and published definitions of SDM, they were not
designed to understand what needs to have happened in a specific decision making context for a
patient to label it as a shared decision. Thus, while it is known that patient reports of SDM are
what drive the link between SDM and outcomes, 101 it is unclear whether patient perceptions of
SDM about a specific, recent decision are related to their perceptions or ideals about SDM.
The aims of this qualitative study are: (1) to develop a conceptual model of patientdefined SDM, (2) to compare this conceptual definition with patient descriptions of a specific,
decision-making process they labeled as shared on the modified Control Preference Scale and,
(3) to contrast patient perceptions with Charles et al.’s theoretical model of SDM.
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Methods
Study setting and participant recruitment
Participants were recruited from an academic and safety net health system in Virginia.
The health system’s electronic scheduling system was queried to identify adults aged 50 to 75
years with a non-follow-up primary care visit in the general internal medicine or family medicine
out-patient clinic scheduled in the next month. Among these age-eligible patients, the electronic
medical record was queried for those who were due for colorectal cancer screening as specified
by the U.S. Preventive Services Task Force. 24 These patients were mailed a letter of study
introduction two weeks prior to their scheduled appointment. Within one week after their
scheduled appointment, patients who had not declined participation were contacted via telephone
by the principal investigator (LAS). At that time, eligibility was confirmed and among those
eligible and agreeing to participate, verbal consent was obtained. Recruitment continued until
theoretical saturation was met. 105 All aspects of the study were approved by the Virginia
Commonwealth University internal review board.
Data collection
Study participation entailed completion of one telephone interview lasting approximately
45 minutes. The interviews were conducted by the principal investigator (LAS) using a semistructured interview guide. (See Box 3.1 for specific questions from the interview guide used in
this analysis; see Appendix A for full interview guide.) Participants were first asked to recall
and describe any decisions made in their most recent primary care appointment. They were then
asked to indicate how the decision was made using the modified Control Preferences Scale, 12
and to describe what during the visit led them to perceive that the decision was made this way.
Following these questions, participants were asked about the meaning of SDM more broadly,
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with the question, “Now, thinking more generally, this doesn’t have to be about your recent visit
with [your doctor]: What does the phrase “My doctor and I shared responsibility in deciding,”
mean to you?” Finally, participants were asked about their perceptions of the patient and
physician responsibilities in a SDM process. All interviews were audio-recorded.

Box 3.1: Selected questions from semi-structured interview guide
1. Let’s start by talking about some of the topics that you and Dr.__ discussed during your
most recent visit. Please tell me what topics you discussed.
2. Were any decisions made about any of these topics? Which ones?
3. I’d like to hear more about the decision about <topic>? How was that decision made?
4. Now I am going to read you 5 choices for how the decision was made. There are no right
or wrong ways to make the decision, so none of these choices are better or worse.
5. When it came to making the decision about <topic>, which of these would you say would
best describe how the decision was made?
a.
b.
c.
d.
e.

I made the final decision.
I made the final decision after seriously considering my doctor’s opinion.
My doctor and I shared the responsibility for deciding.
My doctor made the final decision after seriously considered my opinion.
My doctor made the final decision.

6. What makes you feel that the decision about <topic> was <type of decision chosen in
Question 4>?
a. What specific things happened during the visit that made you feel that <type of
decision chosen in Q4>?
b. What specific things did your doctor do or say that made you feel this way?
c. What specific things did you do or say that made you feel this way?
d. If someone were to have audio-recorded or video-recorded your visit with Dr. X,
how would they have known from the audio or video that the decision was <type
of decision choices in Q4>?
7. Now, thinking more generally, this doesn’t have to be about your recent visit with Dr. X.
What does the phrase “My doctor and I shared responsibility in deciding” mean to you?
8. What things must you, as a patient, do during the conversation for you to consider a
health care decision to be shared between you and the doctor?
9. What things must the doctor do during the conversation for you to consider a health care
decision to be shared between you and the doctor?
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Data analysis
Prior to analysis, all audio-recordings were transcribed. A qualitative content analysis
approach was used to analyze interview data. Coding and analysis occurred concurrently with
subsequent interviews and proceeded in three phases: immersion, reduction, and interpretation.
106

During immersion, audio-recordings were listened to and transcripts read several times to

identify emerging themes. The reduction phase consisted of creating initial codes, developing a
coding scheme, and coding the interviews using ATLAS.ti. Coding consisted of both a priori
codes informed by prior literature on SDM and inductive codes using the patients’ own words
about SDM. The principal investigator developed a preliminary coding scheme early in the
analysis process and, in discussion with the coauthor, revised it using an iterative process as new
relevant themes arose (see Appendix B for full list of codes). Once the conceptual model of
patient-defined SDM was developed, the patient descriptions of decisions made during their
recent primary care visit were coded with the same codes to allow for comparison of responses.
The interpretation phase consisted of reorganizing the data into categories that help address the
research questions and drawing conclusions from the data. 106 Memos were kept throughout the
process to document the decisions made and help with interpretation. 105
Results
Sample characteristics
A total of 60 patients were identified as potentially eligible, mailed a letter of study
introduction, and called to assess willingness and eligibility. Among these, 21 were not
reachable by phone, 14 declined participation, and two wished to participate but were ineligible
due to not attending their recently scheduled primary care visit. In total, 23 patients were
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interviewed. Table 3.1 provides the characteristics of each patient in the sample. Patient
participants were primarily female (61%) and Caucasian (74%). The mean participant age was
63 years (SD = 10.4).

Table 3.1: Sample characteristics
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Patients’ conceptual definition of shared decision making
When asked about the meaning of shared decision making in general, respondents
described two key phases of SDM: an interactive exchange and making the decision. The
interactive exchange phase consisted of four interdependent components: sharing information,
active listening, patient self-advocacy, and a personalized physician recommendation (Figure
3.1). Additionally, a cross-cutting theme emerged that spanned across the phases of SDM and,
which patients describe as being essential: the need for a trusting relationship that extends
beyond a single encounter. No differences were noted in patient conceptual definitions of SDM
by patient age or race. The following section describes these phases and related themes of
patient perceptions of SDM.
Phase 1: An interactive exchange
All patients described SDM as a collaborative process in which both the patient and
physician are active participants. Patients described four iterative components that make up the
interactive exchange phase of shared decision making: a mutual exchange of information, active
listening, patient self-advocacy, and the physician making a personalized recommendation.
Component 1: Mutual exchange of information
Patients nearly unanimously brought up the importance of a mutual exchange of
information in which the patient shares any relevant concerns or problems and the physician
shares medical and treatment information. This interactive information exchange process
included “input from both sides” (Pt18). Patients described specific roles for both themselves
and for physicians in the exchange of information.
First, patients are responsible to describe their symptoms and health concerns to their
physician, so that their physician had the basic knowledge to begin forming a recommendation.
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Figure 3.1: Patients’ conceptual definition of SDM

For example, one patient said, “They can’t read your mind. If you don’t go in on your visit and
tell them everything that’s going on for whatever your problem happens to be, they can’t really
help you,” (Pt22). Beyond simply describing symptoms, patients acknowledged a need to be
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completely open with their physician about anything that might affect their health, even if the
topic is uncomfortable. Many patients brought up the concept of “honesty”, noting its
importance in reaching the best possible decision. One patient described this with, “The patient
needs to have shared everything that's going on that might possibly be contributory to whatever's
happening, whether that's casual drug use or whatever… I think you'd have to have made the
decision to be open and honest with the physician,” (Pt17). Another said, “You (need to) be
honest with the doctor. Just like a priest. You can tell the doctor everything. And you should,
because they cannot treat you to your best advantage if they don't know everything.” (Pt 8)
Patients acknowledged that physicians also have the responsibility to share information.
Specifically, according to patients, physicians should share any relevant medical information and
treatment options, taking the time to clearly explain in language that is understandable to
patients. One patient described this, saying that it is important, “that your doctor tell you what’s
going’ on, explain your options to you,” (Pt13). Another described the importance of the
physician taking the time, “to explain what I had, to explain the medication. So, I knew exactly
what it was for, how to use it,” (Pt 10).
Component 2: Active listening by both parties
In addition to sharing information, many patients specifically described listening as an
important component of SDM. Patients were clear in their beliefs that both physicians and
patients bring their own specific expertise to the interaction. Physicians bring medical expertise
and training while patients have unique knowledge about their own body and symptoms. Thus,
acknowledging the physician’s medical expertise, patients stated that they should listen and beopen minded about what the physician says.
“I have to be very open and honest to her and I also have to be open minded enough, and
I know that this is hard sometimes for me, open minded enough that if she recommends
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something that's a little unusual that I really need to seriously consider that because I
know she's doing what she feels is best for me.” (Pt8)
Likewise, patients stated that physicians should also take the time to listen to and
understand patients. This takes the form of an interactive conversation rather than the physician
simply providing medical information. Patients described two ways that they understood
physicians to be listening to them. First, when a physician makes time to talk with a patient on a
more personal level, this helps the patient to be assured that the physician sees them as an
individual person with unique circumstances and needs. Patients desired to see this type of
active listening throughout the visit, not only during the discussion about the particular decision
at hand.
“I think they just have to be very open and not rush and talk so fast and talk in ‘doctorese’ that you don't understand them-that if they can just look at you and-like you're a
person and not patient number 93.” (Pt15)
Second, patients wanted physicians to respect the expertise that they bring to the visit. To do
this, physicians should carefully listen to patients, solicit their thoughts and concerns, and take
time to answer questions before forming a recommendation.
“The doctor has the training and the knowledge and everything, but I feel that the doctor
needs to listen to the patient, listen to what they’re saying. The doctor sees you for half
hour, 15 minute appointments or whatever… you live with yourself” (Pt2)
Component 3: Patient self-advocacy
Patients described a responsibility to advocate for themselves throughout the SDM
process. This may consist of asking questions if clarification is needed, guiding the conversation
if the physician gets off track, sharing opinions, and speaking up if there are hesitations or
disagreements. As one patient stated, “if you don’t feel right about something; don’t be afraid to
challenge that doctor to get the information that you really want to have,” (Pt 4). Similarly,
another said, “If you have a doubt, talk about it. Be prepared with questions. If it's something
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serious, have your questions down. Don't be afraid,” (Pt7). Like active listening, patients
described the importance of these self-advocacy behaviors not only during the decision-making
process, but also extending to all parts of the visit. By engaging in this way, patients viewed
themselves as actively contributing to the formation of the best possible decision.
Component 4: Physician makes a personalized recommendation
Most patients seemed to take it for granted that physicians should provide a
recommendation for action, whether for treatment or no treatment, during the discussion.
However, they had specific thoughts about how these recommendations should be made. First,
patients wanted to feel the physician knew and understood them before making the
recommendation. As one patient put it, “I don't want doctors telling me what's best for me
without me knowing that they understand what's best for me from my point of view,” (Pt7).
In order for patients to feel confident that these recommendations are based on the
individual patient and their unique situation, rather than relying only on what the physician
typically recommends, patients reported that physicians must take the time to explain the
reasoning behind their recommendations. For example, one patient said they’d like physicians to
“explain the reason for a certain procedure or an appointment with a specialist or whatever. It’s
helpful to me, and I think it would be for most patients, to understand why something is being
suggested,” (Pt 12). Patients want to understand both the benefits of the treatment or procedure
in general as well as why it is specifically recommended for them. Additionally, the words that
physicians use to make the recommendations to patients affect patients’ perceptions of SDM.
Patients stated that they want physicians to make suggestions or give options, not demands or
ultimatums. One patient gave an example of how this type of personalized recommendation
might play out in practice:
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“The doctor has to be willing to defer somewhat what might be convenient for him or
something that he’s more comfortable doing… I just think there has to be a lot of
interaction and dialog rather than just dictating orders to patients. Like we’re going to
put you in the hospital tomorrow and we’re going to do this and we’re going to do that.
Let’s slow down here a minute and let’s talk about this. How about if I put this off for a
month? What’s the consequence of doing that? How about we don’t put me in the
hospital at all? The patient’s got to be active. Being active, the doctor’s got to be
receptive to that and willing to work-willing to take the time that’s necessary to explain if
he has strong views about why that idea is the best one.”(Pt14)
Phase 2: Making the decision
Following the collaborative exchange between the patient and physician in which
information was shared and a personalized recommendation was provided, patients then said that
a decision is made that is in the best interest of the patient. Patients generally described one of
two perspectives about how the decision was made. About half of the patients (n=11) described
decision making as mutual between the patient and physician. One patient described the
decision-making process with, “You and your doctor talk over all the options and come up with a
shared thought about what’s the right way to do it,” (Pt1). Another said, “Well, for me that
means that we thoroughly talk about any issues, concerns that I have and he has, and that we
come to some agreement around treatment or non-treatment or whatever we're going to do.”
(Pt6)
The other half of patients (n=12), however, stated that ultimately the patient always
decides, even in a SDM process. These patients acknowledged that the patient has to take final
responsibility, even if they shared in the communication process leading to the decision. One
patient said, “It’s a collaborative thing, but I mean I clearly feel that it’s my decision. I also
assume that my doctors share that assumption… but yeah I’m the decision maker” (Pt16).
Another patient described the distinction between a shared process and the final decision with,
“I’m thinking sharing, that’s the way it should be. I mean they can give you their
opinion, but it’s something that you’ve got to live with. I mean, I know you’re going to
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them because they went to school for many years or whatever, but ultimately it’s still
your life and your body.” (Pt20)
Crosscutting Theme: Trusting relationship built over time
Patients also pointed to the importance of a strong rapport when describing SDM.
Prominent among this was the need for the patient to trust that the physician knows them and
understands their health care needs and preferences. As described by patients, the building of
this trust is not confined to the communication around a particular decision itself, but is built
over time and extends beyond a single visit. As one patient stated,
I think you just have to find a doctor you trust, not because he's the best doctor out there
and somebody else recommended him. That's nice, but what's the sense of having the
best doctor out there if you don't have trust in him and you can't talk to them, you know?
(Pt 7)
A trusting relationship allows for both patient and physician to feel comfortable throughout the
collaborative exchange to speak up if they are uncomfortable, and for a high quality,
personalized decision to be made. One patient described how this trusting relationship with his
physician helps him to make high quality decisions.
It's wonderful that I have a strong relationship with [my doctor] because I think those are
the kinds of relationships that are hard to come by these days in medical care. I think he's
especially good at making sure that I'm comfortable with decisions. There have been
occasions where he's sensed that I have some concerns, and he's gone ahead and referred
me when I suspect that he's been fairly sure about his decisions, but he wants to make
certain that I'm comfortable, and he's comfortable too. (Pt6)
Decision-making processes that patient label as shared
Patients were also asked to describe any decisions that they made in their recent primary
care appointment. A total of 33 unique decisions were described across the 23 interviews. The
reported number of decisions made during the recent primary care visit ranged from zero to
three, with a median of one decision per visit. The context of the decisions was varied and
included decisions about adding or changing medications (n=11), ordering diagnostic tests (n=
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9), referrals to specialists (n=5), cancer screening (n=4), ordering “routine” blood work (n=2),
prescribing a vaccine (n=1), or changing health behaviors (n=1). Of these 33 decisions, 15
(45%) were reported as being shared decisions on the modified Control Preference Scale 12
(option 3), 13 (40%) were reported as patient-led decisions (option 1 or 2), and 5 (15%)
physician-led decisions (option 4 or 5).
Across the 15 decisions that patients labeled as shared, the level of communication
between the patient and physician described by patients as having occurred varied greatly,
ranging from extremely short and simple exchanges to lengthy discussions. The only
commonality found across the 15 decisions that patients labeled shared was that the patient and
physician ultimately came to an agreement. Further analysis revealed three general patterns of
communication: simple agreement by the patient to a physician recommendation, patient
pushback to a physician recommendation, and a patient-led recommendation. In this section we
apply the phases and themes of patients’ conceptual definition of SDM to the patient descriptions
of the specific decisions that they labeled as shared within each of the three general patterns of
communication.
For a third of the decisions labeled as shared (n=5), patients described a straightforward
process in which their physician made a recommendation and the patient simply agreed. In this
situation, very little communication exchange seemed necessary to consider the decision to be
shared. In these cases of simple agreement, the only component of the patient conceptual
definition of SDM that was reported was a physician recommendation. However, even these
recommendations did not meet the full requirements of a personalized recommendation where
the physician explained both why the procedure is suggested in general and for the individual
patient in particular. Rather, patients described very straightforward recommendations without

!

@(!

!
!

an active exchange of information. Below are two of these patient descriptions of decisions
labeled as shared that included only simple interactions:
“She just said, if I hadn’t had [a bone density scan] in three years, and I said, oh, I know
it’d been longer than three years. She said, “Well then I think you should have one,” and
I said fine. That’s fine with me. So that’s a shared… She didn’t say to me, you have to
have this. I mean, you know, we discussed it, and we both agreed. So that’s shared.”
(Pt1)
“She said I would suggest as long as you fasted, you might as well take it [blood work for
liver function] if you want. And so she was-and then when I said yes, she said that's a
good idea. To me, I felt it was a mutual thing. I could have said, well, nah, let's wait
until next six months and-but she said you might as well do it now.” (Pt15)
In other cases, a physician made a recommendation and the patient had questions or
hesitation (n=6; 40%). After discussion, the two parties ultimately came to agreement, and this
was also labeled as a SDM process. In this situation, patients described various levels of
interaction that ranged from simple questions and recommendations to much more detailed
discussions. These decisions most closely resembled the conceptual model of patient-defined
SDM. That is, patients described some exchange of information, active listening on the part of
the physician, patient self-advocacy (including questions of clarification, expressing differing
opinions, and soliciting the physician’s opinion about alternative options), and all contained a
physician recommendation. For example, one patient described the decision with the following:
“He said, given your history, I might like to consider medication [to lower cholesterol]…
I felt that, at this point, I really don't want to take another medicine. I would like to try
other methods before even considering going on medication… He listened to what I felt,
my point of view or whatever. It wasn't a snap judgment, ‘Okay, your cholesterol is up
and you're going to go on medication, and that's that.’ He listened and after discussion,
and I said that I was reluctant to take medication at this time. He agreed, ‘Okay, we can
wait and see how the other methods are working.’” (Pt2)
The third type of shared decision described by patients involved a patient bringing in a
specific request for the physician (n=4; 27%). These situations differed from the conceptual
SDM process described by patients, because the patient was the party who made the initial
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recommendation. The communication process after the patient recommendation was typically
described as being similar to those in the first category who had simple agreement with their
physician. That is, very little communication exchange seemed to be necessary to label these
decisions as shared.
“Well, I just I brought it up. I had been in my local pharmacy a couple months ago and I
saw they were offering [the shingles vaccine] there… I’d had two scary incidents with
shingles over the course of the last 20 years; both involving it appearing in my scalp and
near my eyes. I wanted to-I’m very interested in getting that preventive vaccine so I
don’t have another outbreak of it…He said, ‘I’ll be happy to write that prescription for
you.’ I said, ‘Good, let’s give it a shot.’…I wanted to get it and he thought I needed it so
it was a pretty mutual decision.” (Pt14).
Across all three of these interaction types, when asked about why a recent, specific
decision was labeled as shared, the concept of a relationship of trust did not arise explicitly in the
way that it did when patients described the process of SDM in general. Only one patient directly
addressed trust when asked about why a specific decision was perceived as shared.
“She (was) sharing with me the medical complications of taking it or not taking it. I'm
sharing with her some of the things that I know that might have influenced it. It's a give
and take. I think both of us, if you would've heard that, it would've sounded like we were
both being respectful of each other…Anyway, it has to do with trust that the other one is
genuine-that we were jointly doing this. It's a trust issue, and I think you could hear that
in the conversation.” (Pt 17).
However, for most patients, particularly those who described an interaction characterized by
simple agreement with the physician, trust was not mentioned. In these conversations, however,
the manner in which the patients described themselves as easily agreeing with physician
recommendations implies some level of trust in the physician’s medical opinions (see
descriptions of decisions above).
In summary, despite the diversity of interactions labeled as shared, two important
commonalities existed. First, except where a patient brought in their own specific request for the
physician, all discussions that patients labeled as shared included a physician recommendation
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for treatment or non-treatment. Second, all patient-perceived shared decisions ended in
agreement between the patient and physician. Furthermore, in the cases labeled as shared
decisions where patients agreed quickly with the physician’s recommendation, very little
communication process at all was described. Thus, patient perceptions of having participated in
a shared decision may be more about the outcome of agreement with a physician
recommendation rather than any specific communication process.
Patient perceptions of SDM compared to Charles et al.’s theoretical model of SDM
When asked about the meaning of SDM in general, patients describe an interactive
communication process that is similar to the commonly used definition of SDM developed by
Charles and colleagues (1997, 1999). My findings point to the importance of active participation
and a mutual exchange of information (see Table 3.2). However, in the hypothetical at least,
patients state that they want physicians to listen if they have a treatment preference to express,
but that expressing a preference is not a necessary component of SDM. Similarly, patients
acknowledge that there are times when they may participate in a SDM process but ultimately not
agree on the decision. Thus, patients’ conceptual definition of SDM does not support the
necessity of characteristics 3 and 4 (both participants sharing their treatment preferences and
reaching agreement around the decision) in the Charles et al. definition in order for a decision to
be considered shared. In contrast, when patients are asked to describe a specific, recent shared
decision, there was no consensus about the specific communication content needed for a decision
to be considered shared. Rather, patients focused on their agreement with a physician
recommendation (Charles et al. characteristic 4).
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Table 3.2: Comparison of patient conceptual definition of SDM to patient experiences with
a recent shared decision and a theoretical definition of SDM
Charles et al
(1997, 1999)

Patient
conceptual
definition of SDM

Both patient and physician are
actively involved

!

!

Both patient and physician share
information

!

!

Both patient and physician share
treatment preferences

!

Both patient and physician reach an
agreement on decision

!

Patient experiences with
a recent, specific decision
labeled as shared

Characteristics from Charles et al.

!

New communication components
Both patient and physician actively
listen to one another

!

Patient advocates for self throughout
the visit

!

Physician makes a personalized
recommendation

!

Rapport extending beyond a single
encounter

!

In addition to these communication components, these findings contribute several new
themes to patient definitions of SDM. First, when asked about their conceptual definition of
SDM, patients described a desire for care that is tailored to the individual patient in their specific
circumstances. In order to accomplish this, patients want to feel that the physician understands
their individual needs and opinions and has used this understanding when making a
recommendation among various medical options. They emphasized the importance of both
patient and physician actively listening to one another and being open-minded to
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recommendations outside of what they might be accustomed to doing if it is in the best interest
of the individual patient. Second, patients described an important aspect of their role in SDM to
be advocating for themselves. Self-advocacy includes such responsibilities as being prepared for
the visit, asking hard questions, speaking up if there is hesitation, and ultimately asking for a
second opinion if desired. Finally, in order for both personalized care and patient self-advocacy
to be possible, patients in our study also described the importance of a trusting relationship that
is built over time, and extends beyond a single encounter.
Discussion
Patient perceptions of the meaning of shared decision making about a recent, specific
decision differ from their conceptual definition of SDM. When asked about SDM in general,
patients described two phases: an interactive exchange and making a decision. The interactive
exchange is a collaborative process that includes four interdependent components: sharing of
information, active listening, patient self-advocacy, and a personalized physician
recommendation. On the other hand, when patients labeled a recent, specific decision as being
shared, they described a variety of communication processes ranging from simple agreement
with little or no discussion, through a more interactive process similar to that which would be
labeled as SDM using currently accepted definitions. Common across all decisions perceived as
shared was ultimate agreement between the patient and physician. Thus, while patient
conceptual definitions of SDM center around interactive communication processes, patient
perceptions of having participated in a shared decision may be more related to the outcome of
agreement with a physician recommendation rather than any specific communication process
that led to this agreement.
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These findings have implications for both the measurement of SDM as well as
intervention design. Results from my interviews indicate that SDM, when measured by
instruments such as the modified Control Preference Scale, likely does not reflect patient
perceptions about the communication process itself. Thus, if the purpose of a study is to
understand patient’s perceptions of a communication process, the modified Control Preference
Scale may not be an appropriate tool. Degner’s Control Preference Scale was designed to
measure preferences for level of involvement in decision-making rather than perceptions about
what actually occurred. 12 Although it is widely used in its modified form to measure perceptions
of involvement, my findings indicate that it may not measure this concept well.
My findings also have implications for the measurement of SDM beyond a patient’s
perspective. In these interviews, patients described their own role in the information exchange
and decision-making as being as active as or more active than the physician role. However,
many of the most commonly used measurement tools for SDM (including the OPTION scale 9)
focus solely on physician behaviors and thus may be missing important aspects of the
interaction. Similar to other recent qualitative studies, 21,22 my findings point to the importance of
relational factors within the visit on patient perceptions of SDM. However, patients in this study
also emphasized the importance of relational factors beyond the current visit and described the
importance of a trust between the patient and physician that is built over time. Thus, findings
from this study provide support for others who have called for the measurement of SDM as part
of a larger interaction and relationship rather than focus solely on the discussion specific to the
current decision. 107
In interviews, patients spoke of the importance of advocating for oneself in order to fully
participate in a SDM process. Thus there may be a need for interventions that encourage patient
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self-advocacy such as asking questions, speaking up when uncomfortable, or asking for a second
opinion. Past studies have shown that when patients are more active in their consultations,
physicians both share more information 108 and adopt a more patient-centered style of
communication. 109 Interventions to promote patient participation and self-advocacy could
include communication training for either the patient or the physician. Patient interventions
might include communication training that builds skills on assertiveness and question-asking.
Physician interventions could provide training around creating a trusting environment that would
allow patients to feel comfortable speaking up.
There are several potential explanations for my finding that patient reports of SDM about
a specific, recent decision seem to be more about the outcome of agreement than the
communication process experienced. First, it is plausible that the wording of the choices
themselves, led patients to think of an outcome rather than a process. In these interviews I used
the modified Control Preference Scale, which asks patients to respond to the following question:
“When it came to making the decision about <the specific topic>, which of these would you say
would best describe how the decision was made?” The option that represents SDM is, “My
doctor and I shared responsibility for deciding.” “Shared” in this context may be more about
shared agreement rather than a detailed collaborative (shared) process. Furthermore, if patients
have an expectation that they will talk respectfully with their physician and come to agreement
on a plan, and this expectation is met, patients are not likely to consider the process that led to
the accomplished goal. This makes sense in light of communication theory, such as Expectancy
Violations Theory, 110 which posits that when a person’s expectations of the interaction are
violated, their focus changes from the original purpose of the interaction (agreement on a
treatment plan) to thinking about the source of the discrepancy (or the communication process
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itself). Thus, unless a patient’s implicit expectation is violated with extremely poor or
disrespectful communication, the patient is not likely to think about the communication process
itself, but rather stay focused on the goals of the consultation.
Despite past studies indicating that differences in preferences for level of involvement
and reports of participating in SDM by age 111,112 (Frosh & Kaplan, 1999; Levinson et al., 2004)
and race, 113,114 my study did not find any differences in patient perceptions of the meaning SDM
by age or race. This may indicate that age and racial differences in reports of shared decisions
lie in actual differences in occurrence rather than in differences in the way patients define SDM.
This study has several potential limitations. Patients described a diverse array of topics
for which decisions were made during their primary care visits. The small sample size, while
appropriate for the aims of the qualitative study, did not allow me to examine perceptions by the
context of the decision or the existing relationship the patient has with the physician seen. Thus I
do not know whether patient perceptions of what constitutes a shared decision might vary by
decision context. Second, I sampled patients who had recently attended a non-follow up primary
care appointment. Thus, this sample may represent patients who are more active in their
healthcare and perceptions of SDM may differ for those who take a less active approach.
Finally, while we did not find any difference in patient perceptions of SDM by age or race, we
did not have access to their level of educational attainment. Future studies may want to explore
whether level of education affects how patients perceive SDM in both conceptually and
regarding a specific, recent decision.
Conclusion
Patient reports of making a shared decision have been linked with improved patient
outcomes. 101 However in order to foster the communication linked with these outcomes in
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practice, a clear understanding of what leads a patient to label a decision as shared is needed.
This study makes an important contribution to the SDM literature by focusing specifically on the
patient perspective of SDM. While SDM is often advocated on ethical grounds as a means to
improve patient autonomy, the voice of the patient is notably lacking in most studies. The results
presented here help to bridge this gap and allow for a better understanding of how patients
conceptually define SDM as well what leads them to label a decision as shared. My findings
indicate that patients have a clear idea of how they define SDM in general. Conceptually,
patients describe a SDM process similar to accepted models of SDM in the literature, but with a
greater emphasis on active listening and relational factors that are influenced by a relationship
built over time. However, in the context of a specific, recent primary care decision, when
agreement is reached about the decision, patients may perceive even relatively simple
interactions as being shared decisions. Thus, it seems there is no one-size-fits all process that
leads patients to perceive a decision as being shared. Rather, the outcome of “agreement” may
be more important than the actual decision making process used to reach that agreement when
patients label a recent decision as shared.
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Chapter 4: Patient-defined shared decision making and colorectal cancer screening
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Abstract

Introduction: The U.S. Preventive Services Task Force advises that physicians use a shared
decision making (SDM) process when recommending preventive services, such as colorectal
cancers screening. The aim of this study is to determine whether the occurrence of the four
components of patient-defined SDM (exchange of information, physician active listening, patient
self-advocacy, and a personalized physician recommendation) are associated with adherence to
physician-recommended colorectal cancer screening, and whether this relationship is moderated
by the patient’s initial verbal response to the physician recommendation.
Methods: Secondary analysis of a dataset of 410 audio-recordings of primary care visits that
included a physician recommendation for colorectal cancer screening. Audio-recordings were
coded for the four components of patient-defined SDM as well as the patient’s initial verbal
response to the recommendation. Colorectal cancer screening use in the following year was
available via electronic medical records.
Results: The most commonly observed component of patient-defined SDM was patient selfadvocacy (76%), followed by physician exchange of information (61%), physician active
listening (60%), and a personalized physician recommendation (23%). Only 35 visits (9%)
contained all four patient-defined SDM components. In adjusted models, physician provision of
information around the process and potential side effects of colorectal cancer screening was
associated with an increase in screening. Patients who initially refused were least likely to be
screened (40%), while patients who did not verbalize a response to the recommendation were
most likely to be screened (70%). The screening rate among patients who initially verbally
agreed with the recommendation was not different than the overall screening rate (49% vs. 55%).
Discussion: My findings point to the importance of providing all patients with information
alongside a recommendation for colorectal cancer screening. Even patients who initially agree to
recommendations may have questions or concerns that would benefit from an interactive
discussion.
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Introduction
In the United States, colorectal cancer is the third leading cause of cancer death for both
men and women. Despite being a preventable cancer if polyps are discovered and removed
early, approximately 40% of people for whom screening is recommended remain unscreened. 25
Having a physician recommendation for screening is one of the best predictors of colorectal
cancer screening (CRCS) use. 115 When making these types of preventive service
recommendations, the U.S. Preventive Services Task Force (USPSTF) advises that physicians
use a shared decision making (SDM) process. Patients who report good communication with
their physician, including involvement in shared decision making, are more likely to be adherent
to colorectal cancer screening recommendations. 34
Until recently it was not clear what patients actually meant when they endorsed a
decision as being shared, making it difficult to advocate for specific communication practices
that promote adherence to colorectal cancer screening. Results from three recent qualitative
studies, however, enable a better understanding of the communication processes that patients
label as “shared”. 21,22,116 Collectively these studies find that patients value an interactive process
in which the patient and physician share information and through which the patient feels listened
to and understood before making a medical decision. Furthermore, the results from Shay (2013)
highlight differences in the way patients define SDM by a patient’s initial level of agreement
with the physician’s recommendation. 116 That is, when a patient agrees with a physician’s
recommendation, a less complex interaction may be needed for the patient to perceive the
decision as shared relative to when the patient initially disagrees or has some hesitancy towards
the physician’s recommendation. Thus to promote adherence to physician-recommended
colorectal cancer screening in practice, it may be important to understand not only which specific
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patient-physician communication components effect screening use, but whether the impact of
these components differs by the patient’s initial reaction to the colorectal cancer screening
recommendation.
The current study uses the model of patient-defined SDM developed by Shay (2013) to
determine whether and which components of SDM are associated with adherence to physicianrecommended colorectal cancer screening and whether the relationship between these
components and adherence to colorectal cancer screening is moderated by the patient’s initial
reaction to the physician recommendation.
Methods
Conceptual framework
The conceptual framework informing the study design and variable selection was adapted
from two existing models (Figure 4.1). The Communication Model of SDM posits that
patient/provider communication is transactional, involving two engaged participants, and
acknowledges that decisions are influenced by both pre-existing individual patient and physician
characteristics and the communication climate in which the decision takes place. 117 Second, the
model of patient-defined SDM developed by Shay (2013) involves an interactive exchange
between the patient and physician that is made up of four interdependent components: physician
exchange of information specific to the decision at hand, physician active listening throughout
the visit, patient self-advocacy throughout the visit, and personalized physician recommendation.
Data Sources
Data for the current analysis come from an observational study of patient-physician
communication in the context of colorectal cancer screening. 19,103,118 For that study, 64 primary
care physicians and 500 of their patients in an integrated health system in southeast Michigan
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Figure 4.1 Conceptual framework adapted from Siminoff & Step (2005) and Shay (2013)
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were enrolled between February 2007 and 2009. Eligible physicians included salaried family
and internal medicine physicians on staff with a large integrated health system. Eligible patients
were aged 50 to 80 years, insured via the health system affiliated HMO, and due for colorectal
screening at the time of their scheduled period health exam with a study participating physician.
Details of the recruitment and enrollment processes have been published elsewhere. 19,103,118
Data were collected via pre-visit patient surveys, audio-recordings of the office visits,
health system records, and the electronic medical record. Research assistants administered previsit surveys via the telephone at the time of recruitment that included measures of sociodemographic characteristics, patient preferences for role in decision-making, and patient
perceptions of their physician (among those who had previously seen the same physician).
Patient and physician communication during the office visit was captured via a small digital
recording device. All audio-recordings were transcribed prior to coding. Physician
characteristics, including age, gender, race, and medical specialty (family or general internal
medicine) were obtained from health system records. All aspects of the current research protocol
were approved by Virginia Commonwealth University’s Institutional Review Board.
Dependent variable: adherence to physician-recommended colorectal cancer screening
The primary outcome in this study is adherence to physician-recommended colorectal
cancer screening in the 12 months following the audio-recorded visit. Screening use was
identified via service codes in the electronic medical record for all screening modalities that were
recommended by the USPSTF at the time of the study, including fecal occult blood test,
colonoscopy, flexible sigmoidoscopy, or double contrast barium enema. 24 Patients were
considered to have been adherent to physician-recommended colorectal cancer screening if, per
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the electronic medical record, they received at least one of these procedures in the year following
their recorded visit.
Explanatory variables: patient-defined SDM and patient’s initial reaction to colorectal
cancer screening recommendation
For this study I am primarily interested in how the components of patient-defined SDM
are associated with adherence to physician-recommended colorectal cancer screening and how
these associations might be moderated by the patient’s initial response to a physician
recommendation for screening. Thus, each of the visit transcripts was coded for the four
components of patient-defined SDM (as depicted in Figure 4.1) and for the patient’s first verbal
indication of their response to a recommendation for colorectal cancer screening.
Each of the components of patient-defined SDM was coded as either present or absent.
Physician sharing of information was coded present if the physician provided information about
the process or side effects of any of the four recommended colorectal cancer screening
modalities (colonoscopy, sigmoidoscopy, fecal occult blood test, or barium enema). Physicians
were considered to have used active listening if they responded to patient comments using
prompted partnership building or supportive. 119 Patient self-advocacy behaviors included asking
questions, expressing concerns, or using assertive responses. 119 Physicians were considered to
have given a personalized recommendation, if he or she provided both general reasoning as to
why colorectal cancer screening is recommended (e.g., early detection, removal of polyps,
disease is asymptomatic, etc.) and a verbal assessment of the individual patient's eligibility for
screening (i.e., due to age, family history, length of time since last screening, or a reference to
the electronic medical record).
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Additionally, each transcript was coded for the patient’s initial verbal response to the
physician’s initial recommendation for colorectal cancer screening. Responses were coded as
either: agreement; hesitation; refusal; or no verbal response. Patients who initially agreed were
those who brought up the topic of colorectal cancer screening themselves, volunteered
willingness, or answered affirmatively when asked directly about their willingness to be screened
(e.g. “I will. I’m going to do it,” or “Oh I know I should.”). Patient responses that were coded
as hesitant were those in which the patient’s first reaction was to ask questions about the
screening (e.g. questions about pain, sedation, need for screening) or those that expressed a
barrier to or concern about screening (e.g. “I don’t have a ride,” or “My mother had it and it was
very painful.”). Initial refusal was coded when a patient volunteered their unwillingness to be
screened or who answered in the negative when asked directly about willingness to be screened
(e.g. “I just don’t want to do it.” or “I feel that I’m healthy and don’t need it.”). Finally, some
patients did not provide a verbal response to the physician recommendation, or only responded
using noncommittal language such as “mm hmm” or “uh huh”. These were coded as no verbal
response.
Coding for the communication elements that made up the four components of patientdefined SDM was done as part of the parent study. 19,103,118 Interrater reliability for these
variables was measured with Cohen’s Kappa and ranged from 0.56 to 1.00. Patient’s initial
response to the recommendation was coded specifically for the current study; the principal
investigator (LAS) conducted this coding. Interrater reliability was assessed by having a random
selection of 10% of the recordings (n=41) coded by a research assistant. Cohen’s Kappa for
patient initial response category was 0.74.
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Control variables: patient characteristics, physician characteristics, and communication
climate factors
The choice of control variables was influenced by my conceptual framework (Figure 4.1).
Pre-existing patient and physician characteristics included patient and physician age, gender, and
race (black, white, and other) as well as patient educational attainment (less than a high school
diploma, high school diploma, some college, college degree or more) and physician specialty
(general internal medicine and family medicine). Pre-existing communication climate factors
included patient preference for level of involvement in cancer screening decisions, 12 nonadherence to a previous recommendation for colorectal cancer screening, patient self-reported
health status, 120 patient reported depressive symptoms, 121 and patient reports of trust in their
physician prior to the recorded visit. 122
Statistical analysis
Data were first considered descriptively. Unadjusted logistic regression was used to
determine whether there were differences in the occurrence of the four patient-defined SDM
components by patient initial response to a physician recommendation for colorectal cancer
screening. Next, simple logistic regression models were used to evaluate whether each of the
components of patient-defined SDM was associated with colorectal cancer screening use and
whether screening use differed by the patient’s initial response to a screening recommendation.
A multiple logistic regression model was then fit to determine the relationship between
colorectal cancer screening receipt, and the components of patient-defined SDM and the
patient’s initial response to screening controlling for pre-existing patient and physician
characteristics and communication climate factors. Finally, interaction terms were added to test
whether the patient’s initial response to a screening recommendation moderated the effect of the
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components of patient-defined SDM on colorectal cancer screening use. Effects coding, or mean
deviant coding, was used in modeling the categorical predictor variables. In contrast to standard
dummy coding, effects coding allows for assessment of the true main effects in models that
include multiple categorical predictors or interaction terms, 123,124 and for the comparison of each
subset of the data to the overall mean (i.e. average screening rate). 123,125 All models were fit in
MPlus with a logistic fit function using all available data. Standard error estimates that corrected
for the non-independence of observations were attained during estimation for all analyses to
control for the clustering of patients by physician.
Results
Sample characteristics
A total of 500 patients consented to participate in the parent study. Ninety of these cases
were excluded from the current analysis for the following reasons: missing or inaudible audio
recording (n=15); no discussion relating to colorectal cancer screening (n=29); already had
screening scheduled at the time of the recorded visit (n=29); office visit discussion indicated
patient not due for screening (n=12); pre-survey data was not available (n=3); screening only
discussed in the context of an ongoing workup for symptoms (n=1); or physician did not
recommend colorectal cancer screening due to current diagnosis of lung cancer (n=1). Thus, the
sample for the current analysis includes 410 patient visits among 64 physicians. Pre-existing
patient and physician characteristics and communication climate factors are depicted in Table
4.1.
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Table 4.1 Pre-existing patient, physician, and communication climate characteristics
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Patient health status was measured in a pre-visit survey with the question, “In general how would you rate your
overall health,” on a scale of 1 to 5 with 5 representing excellent health. Trust in physician was measured in a
pre-visit survey with the statement, “I trust this doctor’s judgment about my medical care.” Patients rated their
agreement on a scale of 1 to 7 with 7 representing “strongly agree”.
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Patient initial response to recommendation and occurrence of patient-defined SDM
components
Across the 410 visits, the most common initial response to a physician recommendation
of colorectal cancer screening was some type of hesitation or pushback from the patient (43%;
Table 4.2). Another 22% of patients were observed to verbally agree with the recommendation,
while about 10% initially refused. For the remaining quarter of patients, there was no verbal
indication of their response to the physician recommendation. The most commonly observed
patient-defined SDM component was patient self-advocacy, which occurred in over threequarters of the visits. More than half of the visits contained an exchange of information around
colorectal cancer screening (61%) and physician active listening (60%). A personalized
physician recommendation for colorectal cancer screening was observed in less than a quarter of
visits (23%). In total, only 35 visits (9%) contained all four components of patient-defined
SDM.
There were significant differences in the occurrence of two of the patient-defined SDM
components by initial response category (Table 4.2). Specifically, patients who verbalized
hesitancy about screening were more likely to receive information about process or potential side
effects of colorectal cancer screening than patients overall (75% vs. 61%; OR: 2.14 95% CI:
1.58, 2.88), while those who agreed or who did not disclose their response were less likely to
have received screening information (For agree: 47% vs. 61%; OR = 0.64; 95% CI: 0.44, 0.92;
For no verbal response: 47% vs. 61% OR: 0.63; 95% CI: 0.47, 0.86). Second, physicians were
more likely to have practiced active listening with patients who initially refused the
recommendation than with patients overall (70% vs. 60%; OR: 1.53; 95% CI: 1.00, 2.34), and
were less likely to actively listen to those who did not verbally respond (51% vs. 60%; OR: 0.67;
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95% CI: 0.49. 0.91). Neither receipt of a personalized physician recommendation nor patient
self-advocacy varied significantly by the patient’s initial response to the recommendation for
screening, but those who verbalized initial hesitancy about the recommendation were most likely
to receive all four components of patient-defined SDM (14% vs. 9%; OR: 2.32; 95% CI: 1.30,
4.11).

Table 4.2 Occurrence of SDM components overall and by patient initial verbal response to
recommendation for colorectal cancer screening
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Relationship between patient-defined SDM components and colorectal cancer screening
Overall, 55% of the sample went on to be screened for colorectal cancer in the year
following their recorded visit. In bivariate analyses, none of the four components of patientdefined SDM individually were significantly associated with colorectal cancer screening
adherence, nor was receipt of all four components (data not shown). However, there were
significant differences in screening rates by the patient’s initial verbal response to the physician
recommendation for colorectal cancer screening. Specifically patients who initially refused were
less likely than the overall sample to be screened (40% vs. 55%; OR: 0.59; 95% CI: 0.35, 0.98),
while those who did not provide a verbal indication of their response were more likely to be
screened (70% vs. 55%; OR: 2.00; 95% CI: 1.37, 2.93). In both the unadjusted and adjusted
main effects models, only patients who did not provide an initial verbal response to the screening
recommendation were significantly more likely to be screened than other patients (Table 4.3,
Models 1 and 2, see page 77).
Interaction between patient-defined SDM components and patient’s initial response to
recommendation
Table 4.4 descriptively displays the percentage of patients who were adherent to their
physician’s colorectal cancer screening recommendation by the patient’s initial response
category and receipt of the SDM components. When the interactions between each of the
patient-defined SDM components and the patient’s initial response to the recommendation are
added to the model (Table 4.3, Model 3), patients who did not provide an initial response to the
screening recommendation remain more likely to be screened (OR: 2.13; 95% CI: 1.30, 3.48),
and those who initially refuse the recommendation remain less likely to be screened (OR: 0.32;
95% CI: 0.12, 0.86). Additionally, in the model that adjusted for the effects of pre-existing
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patient, physician, and communication climate characteristics (Table 4.3, Model 4), patients
who receive information from their physician about the colorectal cancer screening process or its
potential side effects are more likely to be screened than those who do not (OR: 1.78; 95% CI:
1.02, 3.10). None of the interaction terms reached significance in either the unadjusted or
adjusted model.
Table 4.4 Percent adherent to CRCS recommendation by initial response category and
receipt of SDM components
!!

##

=*9/&09>7#/0/9/*.#?&54*.#5&7<807&#

@89*.#
7+5&&0&6#

AGF,,!

J,6=>.5>!

K,LI6,!

]4!C,FH./!
F,68456,!

C#

W!

W!

W!

W!

#

!

!

!

!

!!!!!B^7E.5G,!4L!=5L4F-.>=45!

IIC#

@)W!

@@W!

'%W!

$%W!

!!!!!PE96=7=.5!.7>=C,!/=6>,5=5G!

IFC#

@#W!

@@W!

'(W!

#%W!

!!!!!P,F645./=`,D!F,74--,5D.>=45!

IFC#

'$W!

#"W!

'"W!

$(W!

#

!

!

!

!

!!!!!P.>=,5>!6,/LX.DC47.79!

ILC#

'"W!

@"W!

'"W!

#&W!

!A//!'!74-845,5>6!8F,6,5>!

FFC#

#$W!

$)W!

""W!

#(W!

@89*.#C#7+5&&0&6#4;#/0/9/*.#5&7<807&#

IIC#

KMC#

IKC#

KJC#

NJC#

!
=*9/&09A6&:/0&6#'"B#+83<80&097##
PE96=7=.5XDF=C,5!74-845,5>6!

P.>=,5>XDF=C,5!74-845,5>6!

Discussion
While results here do not provide strong evidence for the effect of patient-defined SDM
on adherence to physician-recommended colorectal cancer screening, I did find that, controlling
for other communication factors, patients who received information about the process or
potential side effects of colorectal screening were more likely to be adherent to their physician’s
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recommendation for screening. Additionally, I found significant differences in both screening
rates and receipt of the components of patient-defined SDM by the patient’s initial verbal
response to their physician’s recommendation for CRC screening. This implies that physicians
tailor their conversation to the patient’s initial verbalized level of agreement with the their
recommendation. Furthermore, while, expectedly, patients who initially refused the
recommendation were those least likely to be screened, it was not patients who expressed initial
agreement with the recommendation, but those who offered no response, who were most likely
to be screened.
In this sample, patient-defined shared decision making in the context of colorectal cancer
screening was not provided consistently across patients. While all visits contained a physician
recommendation for screening, almost 40% of did not include information about the screening
process or its possible side effects. Furthermore, a personalized recommendation, in which the
physician explained why colorectal cancer screening is important in general and for that patient
in particular, was only observed in fewer than one-quarter of visits. In total, only 9% of visits
included all four components of patient-defined SDM, and this was most likely to occur in
patients who expressed hesitancy, but even then only 14% experienced all four elements of
patient-defined SDM. These results support other studies that have found that, in the context of
colorectal cancer screening, shared and informed decision making rarely occurs in practice. 126,127
Thus, evaluating the impact of SDM on colorectal cancer screening in practice remains
problematic.
My results have implications for primary care practice. First, primary care physicians
should be cautious about assuming that they can tell whether a patient intends to be screened or
not based on the patient’s initial, verbal reaction to their recommendation for screening. Results
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here indicate that the majority of patients who initially offer a statement of agreement to a
physician recommendation to be screened for colorectal cancer do not actually do so within the
following year. On the other hand, less than a third who offer no responses at all to their
physician’s screening recommendation remain unscreened one year later. Thus, it would seem
important to engage patients in further discussion regardless of their initial response, providing
patients additional opportunities to express their intents and concerns.
Second, over half of the patients in this sample verbalized some kind of hesitation or
pushback against colorectal cancer screening. As previously reported, in this sample 118 and
elsewhere across the nation, 127 physicians are increasingly recommending colonoscopy for CRC
screening without offering alternatives. When physicians hear hesitancy about colonoscopy, they
should assess whether this hesitancy is for screening in general versus specifically for
colonoscopy. Patients who are resistant to colonoscopies may be more open to the idea of a fecal
occult blood test. 128 A recent trial found that patients offered a choice among modalities were
more likely to be screened. 129 At the very least, physicians should provide information around
the process of colorectal cancer screening to all patients along with their recommendation for
screening. In this sample, those who received such information were significantly more likely to
be screened regardless of their initial verbal response to their physician’s recommendation for
screening.
This study also has implications for future research around SDM and colorectal cancer
screening. In absence of an available measure of the patient’s screening intent at the beginning of
the visit, I relied on the patient’s initial stated level of agreement with the physician
recommendation as a proxy for their initial level of agreement with the recommendation to be
screened. The benefit of relying on patients’ verbal responses is that this is the same information
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that physicians have at the time of the visit. Thus, there is value in evaluating patients’ verbalized
level of agreement, despite the fact that this may not accurately represent the patient’s actual
feelings about the recommendation. However, because this study used audio-recordings instead
of video-recordings or direct observation, I was not able to account for body language that might
have provided additional information about the patients’ initial reactions to the recommendation
for colorectal cancer screening. In order to more fully test the model of patient-defined SDM,
future studies should consider the use of video recordings and measure the patient’s actual intent
to be screened, both before and after the visit, and compare this with verbal responses. Second,
while there has been a trend towards evaluating the effects of SDM on more distal patient
outcomes like adherence 66,69 or blood pressure, 70,84 SDM—whether patient defined or otherwise
measured—is most likely to affect proximal outcomes like satisfaction and decisional regret. 101
While it is valuable to evaluate the effect of patient-physician communication on outcomes such
as adherence or more distal health outcomes, SDM might be better advocated on the grounds of
helping patients make informed and value-concordant decisions. 45,46
This study has several limitations. First, the availability of only one recorded visit per
patient-physician dyad precludes the ability to test for the effects of SDM over time. Many of the
patients in this sample have a long-standing relationship with their physician, and there may have
been more active discussion around colorectal cancer screening in previous visits. I did however
control for trust as expressed by the patient prior to the visit. Also, despite the fairly large
sample size, the power to detect differences is limited by the clustering by physician and the
large number of predictors after the interaction terms were added. Nevertheless, the stability of
my findings when the patient and physician covariates were added suggests robust results.
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In conclusion, further research is needed to fully establish a link between patient-defined
SDM and colorectal cancer screening. However, the results presented here indicate that,
regardless of a patient’s initial reaction to a physician recommendation for screening, those who
are provided with information about the screening process are more likely to be screened in the
following year. Thus, providing information to all patients at the time of a colorectal cancer
screening recommendation is critical, both to allow for more informed decision-making and for
improving colorectal cancer screening rates.
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Table 4.3 Factors associated with colorectal cancer screening
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Chapter 5: Conclusions

The results from the three studies presented in this dissertation build on one another.
First, the systematic review of the measurement of SDM and its effects on patient outcomes
found that SDM is typically measured in one of three ways: via patient-self report; physician
self-report; or objective rating of recorded or observed interactions between patients and
clinicians. Drawing from past theoretical models, 47,48 my review offers a novel categorization
framework for examining the impact of SDM across two domains: the way in which SDM was
measured and the category of patient outcomes (cognitive, behavioral, or health-related). While
there has been a recent trend towards linking (or trying to link) SDM with patient outcomes, 47,9799

this was the first study to systematically summarize the associations between different

measures of SDM and types of patient outcomes.
The systematic review had several important results that guided the direction and
methodology of the subsequent studies. First, only patient reports of SDM were consistently
associated with patient outcomes. Of the 97 unique patient outcomes evaluated in association
with a measure of SDM, 52% of outcomes measured in conjunction with patient reports of SDM
were found to have a significant and positive association, versus only 21% with observer rated,
and 0% with clinician-rated SDM. This finding suggests two important points: the link between
SDM and outcomes has yet to be established, and when there are significant findings only patient
reports of SDM that are consistently linked with patient outcomes. Across studies using patientreports of SDM, the most commonly used measure was a modification of the Control Preference
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Scale. 12 This single item instrument asks patients to rate their involvement in a specific decision
across five categories. What the instrument does not do, however, is aid in an understanding of
what SDM means to patients and what needs to happen in a patient-clinician interaction for a
patient to label a decision as shared. In order to foster the benefits of patient-perceived SDM in
practice, we need a better understanding of what leads patients to report a decision as shared.
Building on these findings, the aims of my second study were to understand how patients
define SDM in general and what leads patients to label a specific decision as shared in practice.
Through in-depth qualitative interviews with 23 patients who had recently attended a primary
care visit, these aims were explored. Findings from this study indicate that patients conceptually
define SDM similar to academic definitions of SDM (e.g. Charles et al. 5), with some important
caveats. Specifically, patients described an interactive process that included four communication
components before a decision was made: an exchange of information; active listening; patient
self-advocacy; and a personalized physician recommendation. Additionally, patients reported
that this process occurs in the context of a trusting relationship that is built over time. In
contrast, when asked about specific decisions made at a recent primary care visit, for that
decision to be labeled as shared using the modified Control Preference Scale, 12 patients
described a variety of exchanges ranging from interactive to very simple. The only commonality
among decisions labeled as shared by patients was that the patient and physician came to
agreement. In cases where patients reported agreeing with their physician’s initial
recommendation, even very simple interactions were labeled as shared. Results from this study,
therefore, indicated that the discussion content that is needed for a patient to label a specific
medical decision as having been shared may vary by the patient’s initial level of agreement to a
physician’s recommendation.
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For my last study I used the conceptual model of SDM that I developed in study two and
coded for the four components of patient-defined SDM in an existing database of audio-recorded
primary care visits. In this study, I explicitly tested whether the occurrence of the components of
patient-defined SDM were associated with adherence to physician-recommended colorectal
cancer screening, and whether the relationship between patient-defined SDM and adherence to
colorectal cancer screening was moderated by the patient’s initial verbal response to the
physician recommendation. This study found that, first, patient-defined SDM was not happening
regularly in the context of colorectal cancer screening discussions. Second, patients who initially
verbally agreed to a physician recommendation for colorectal cancer screening were not more
likely to be screened, and instead it was those who provided no verbal response who were
screened at the highest rates. Finally, physician provision of information about the colorectal
cancer screening process was significantly associated with screening, regardless of the patient’s
initial response to the screening recommendation.
Taken together, the results from these three studies have implications for practice and
research around shared decision making. Patient perceptions of SDM, rather than physician
perceptions or observer ratings based on academic definitions of SDM, are most likely to impact
patient outcomes. The three studies presented here are relatively novel in their explicit focus on
the patient perspective of SDM, giving a voice to those who SDM is meant to benefit. In
contrast with traditional definitions of SDM, patients emphasize the importance of a trusting
relationship and other relational factors. In order to encourage patient-perceived SDM and its
benefits in practice, physicians should work to facilitate trust by actively listening to patients and
providing recommendations that are personalized to the patient based on their unique
circumstances and preferences. Also, while a patient’s initial level of agreement with a
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physician recommendation may affect perceptions of SDM, physicians cannot take verbalized
agreement at face value. Patients who quickly agree with recommendations may not necessarily
adhere. Furthermore, all patients, including those who seem to already agree with a
recommendation, could benefit from the provision of additional information, particularly in the
context of colorectal cancer screening.
My findings also highlight the complexity of studying and measuring shared decision
making. First, definitions of SDM overlap with several other communication processes often
discussed in the literature including informed decision making, patient-centered communication,
action planning, and collaborative goal setting. While the overlap of terms likely cannot be
avoided, researchers should explicitly describe the communication process that they are
studying, and include an operational definition of the term, so that results can be compared
across studies. Second, as the findings from this dissertation demonstrate, both the meaning and
the effect of SDM differ depending on the way it is measured. My systematic review revealed
that the association between SDM and patient outcomes differs by measurement perspective,
with patient self-reports of SDM being more likely to be associated with outcomes than other
types of measures. Additionally, in the qualitative study, patient’s perceptions of SDM differed
by the way they were asked about SDM. Third, the study of SDM is complex because of the
transactional nature of communication between patients and clinicians. 117 The communication
patterns of clinicians effect the communication patterns of patients and vice versa. Therefore, it
is difficult to make any blanket statements about when SDM occurs or when it will have an
effect on outcomes. Both the occurrence and impact of SDM are impacted by a myriad of
factors including, but not limited to, the context and acuity of the decision being made, the prior
relationship between the patient and clinician, that patient’s level of initial agreement with a
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physician recommendation, the match between patient and clinician communication styles and
decision-making preferences, as well as other pre-existing characteristics that patients and
clinicians bring to the encounter. Thus, there is no simple formula for promoting perceptions of
SDM or its associated outcomes.
It is important to note that, due in part to these complexities in studying SDM, the link
between SDM and patient outcomes has yet to be fully established. Relatively few studies have
explicitly measured SDM in association with any patient outcome and even more rarely with
more distal health outcomes. SDM is most likely to be positively associated with patient
outcomes when it was measured via patient self-report and when the outcomes measured were
proximal outcomes like satisfaction or decisional conflict. While this finding may not be
satisfactory to those who wish to link SDM to patient health outcomes, the lack of association is
not surprising. In their model of pathways linking communication to outcomes, Street and
colleagues posit that the effects of SDM on health outcomes are likely to be indirect, with SDM
first impacting more proximal outcomes, 47
Additionally, there is increasing recognition that SDM is a process that often occurs over
the course of multiple visits. 107 Findings from my qualitative interviews supported this, with
patient’s reporting that an essential factor in SDM is a trusting relationship with the physician
that is often built over time. Until now, SDM is almost always measured cross-sectionally in the
context of one interaction or discussion. This may, in part, explain the lack of association
between SDM and patient comes, including colorectal cancer screening adherence. That is, one
discussion between a clinician and patient may not lead to improved health outcomes, but a longstanding relationship between a clinician and patient marked by patient-centered care and SDM
may impact outcomes over time. Future studies should measure multiple outcomes over time so
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that the pathway between communication and health outcomes, such as that proposed by Street
and colleagues, 47 can be tested. For example, SDM may improve patient satisfaction, which
over time may lead to trust in the physician, followed by adherence to physician
recommendations and ultimately improved health. 130 Without longitudinal studies that
specifically test for indirect effects in addition to direct effects, however, the link between SDM
and health outcomes is likely to remain elusive.
In the meantime SDM may be better advocated on ethical grounds. Patient centered care,
including SDM, is important outside of its potential effect on patient health outcomes. First,
most patients want to be actively involved in the decision-making about their medical care, 42
and SDM helps accomplish this goal. Second, SDM is historically rooted in the discipline of
bioethics. One of the earliest mentions of SDM was the 1982 Report of the President’s
Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral.
This report called for a dialogue between patients and practitioners in which both voice opinions
and concerns, and come to a mutually agreed upon decision. Accordingly, the report states that
“ethically valid” consent should be part of a shared decision making process characterized by
mutual respect and participation. 39 More recently, the U.S. Preventive Task Force highlighted
the multiple perspectives on which SDM can be recommended. These included an ethical
mandate to protect patient autonomy and self-determination, an interpersonal benefit of
promoting trust in the patient-clinician relationship, and an educational gain of increasing patient
knowledge about treatment options, benefits, and harms through a SDM process. 3 Thus, despite
only limited evidence that shared decision making improves patient outcomes, there are still
important reasons to advocate for a SDM process when making healthcare decisions.
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Appendix A
Patient Interview Guide
Introduction:
Thank you again for agreeing to participate in this interview. We are interested in
learning about how patients and doctors make decisions. There are no right or
wrong ways to make decisions with doctors. I am interested in hearing about
your experience and opinions.
I am going to ask some questions about how you and your doctor discussed certain
health decisions. Please consider what happened at your most recent visit with your
doctor, Dr X, as we talk.
1. Let’s start by talking about some of the topics that you and Dr.__ discussed
during your most recent visit. Please tell me what topics you discussed.
INTERVIEWER: Prompt (if patient cannot remember any topics):
Sometimes doctors and patients talk about lifestyle choices, preventive
services like cancer screening, medications, etc.
2. Were any decisions made about any of these topics? Which ones?
Prompt with the topics raised in Q1 to see if any decisions were made
about these topics.
INTERVIEWER: List all relevant topics and then review each with
the patient
INTEVIEWER: If no decisions were made about topics listed, ask
about a past health care decision made with a physician that
included some of these topics.
3. I’d like to hear more about the decision about <topic>? How was that decision
made?
4. Now I am going to read you 5 choices for how the decision was made. There are
no right or wrong ways to make the decision, so none of these choices are better
or worse.
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When it came to making the decision about <topic>, which of these would you
say would best describe how the decision was made?
a)
b)
c)
d)
e)

I made the final decision.
I made the final decision after seriously considering my doctor’s opinion.
My doctor and I shared the responsibility for deciding.
My doctor made the final decision after seriously considered my opinion.
My doctor made the final decision.

5. So, you just told me that the decision about <topic> was one made by X/X. Can
you tell me what makes you feel that the decision about <topic> was <type of
decision chosen in Question 4>?
•

What specific things happened during the visit that made you feel that
<type of decision chosen in Q4>?

•

What specific things did your doctor do or say that made you feel this
way?

•

What specific things did you do or say that made you feel this way?

•

If someone were to have audio-recorded or video-recorded your visit with
Dr. X, how would they have known from the audio or video that the
decision was <type of decision choices in Q4>?

•

Is this typical of how you usually make decisions with Dr X?

6. IF THE RESPONSE TO Q4 WAS NOT MARKED AS SHARED (Q4 CHOICE C):
You have shared that you did not feel that the decision you made about <topic>
was shared with your physician. What would have had to happen for you to say
that you and your doctor shared responsibility for deciding about <topic>?
a. What specific things would have had to happen during the visit to make
you think that this decision was shared? OR
i. What would have been different from what actually happened for
you to feel that the decision was shared?
b. What specific things would your doctor have had to do or say?
c. What specific things would you have had to do or say?
***REPEAT QUESTIONS 3-6 ABOUT ALL DECISIONS RAISED IN Q2***

!

**!

!
!

7. What does the phrase “My doctor and I shared responsibility in deciding” mean to
you? What kinds of things do you think of when you hear this phrase?
As you probably know, things have changed in health care and now, many
patients are taking more active roles in making decisions about their health care.
This is often called ‘shared decision making’. What I am interested in learning is
what this means to patients.
8. What do you think of when you hear shared the words, ‘shared decision-making’
between doctors and patients? What does it mean to you?
9. What things must you, as a patient, do during the conversation for you to
consider a health care decision to be shared between you and the doctor?
10. What things must the doctor do during the conversation for you to consider a
health care decision to be shared between you and the doctor?
11. In your opinion, what is the difference between the options “I made the final
decision after seriously considering my doctor’s opinion” and “My doctor and I
shared the responsibility for deciding”?
Can you give me examples of these from your experiences?
12. In your opinion, what is the difference between the options “My doctor made the
final decision after seriously considering my opinion” and “My doctor and I shared
the responsibility for deciding”?
Can you give me examples of these from your experiences?
13. One of the most common definitions of shared decision-making is that four things
have to happen:
1) Both the doctor and the patient have to be actively involved in the
decision-making process
2) Both the doctor and the patient share information with each other
3) Both the doctor and the patient express treatment preferences
4) Both the doctor and patient agree on a decision
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What do you think about this definition of shared decision-making?
Do you think both the doctor and patient have to be actively involved?
Tell me more about that…
Do you think both the doctor and patient need to share information with
each other for the decision to be shared?
Tell me more about that…
Do you think that both the doctor and the patient need to take steps to
build a consensus around the decision for it to be shared?
Tell me more about that…
Do you think that both the doctor and patient need to agree on a decision
for it to be shared?
Tell me more about that…
Would you make any additions or changes to the definition?
If you were making up a definition of shared decision-making, what would it be?
14. Do you think that every single decision made about your health care should be a
shared one between a doctor and patient?
15. Are there differences in how major and minor health decisions should be made?
(examples: lab work, cancer screening (like colonoscopy), treatment
decisions (surgery, cancer treatment, etc.))
16. Is there anything else that I didn’t ask that is important for us to know about
decision-making between doctors and patients?
Thank you so much for your time. We hope that the information you have given
us will help improve decision-making for future patients.
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Appendix B
Final Code List for Patient Interviews
!

Code Name

Description

Q1 - Topics discussed

Code for marking topics discussed in transcript

Q2 - Decisions made

Code for marking decisions made in transcript

Q3 - Description of Decision

Code for marking description of decisions made in
transcript

Context

Codes for marking the context of specific
decision being discussed in questions 3, 4,
and 5

Context - Blood pressure tx
Context - Blood work
Context - Bone density scan
Context - Cholesterol tx
Context - Colonoscopy
Context - Insomnia meds
Context - Mammography
Context - Medication
Context - Referral for procedure
Context - Referral to specialist
Context - Shingles vaccine
Context - Sleep study
Q4

Patient response to the modified control
preference scale in the context of a specific
decision listed in Q3

Q4 - Degner CPS - Pt alone

I made the final decision.

Q4 - Degner CPS - Pt led

I made the final decision after seriously considering
my doctor’s opinion.
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Q4 - Degner CPS - Shared

My doctor and I shared the responsibility for
deciding.

Q4 - Degner CPS - Dr led

My doctor made the final decision after seriously
considered my opinion.

Q4 - Degner CPS - Dr alone

My doctor made the final decision.

When describing a specific decision that they
labeled as shared in Q4 …
Shared type - Simple agreement

patient describes a process in which the doctor
makes a recommendation, and the patient
describes simply agreeing

Shared type - Pt request

patient describes a process in which the patient
brings in a specific request and the physician
agrees

Shared type - Pt pushback

patient describes a process in which the doctor
makes a recommendation, the patient is
hesitant or disagrees and pushes back, they
discuss and ultimately come to agreement

Q5

When asked about a specific decision labeled as
shared...

Q5 - Info

patient brings up the concept of sharing or
exchanging information

Q5 - Info - Dr shares info

patient says the doctor shared information

Q5 - Info - Dr shares inforecommend

patient says that the doctor made a
recommendation

Q5 - Info - Pt shares info expresses concerns

patient says that he/she expressed concerns

Q5 - Info - Pt shares info - shares
symptoms

patient says that he/she shared symptoms or other
problems

Q5 - Listen

patient explicitly brings up the concept of listening

Q5 - Listen - Dr listens

patient explicitly says the their doctor listened

Q5 - Listen - IMPLIED

patient does not use the word "listen" but the
process they describe implies listening

Q5 - Listen - Pt listens

patient explicitly says that they listened to their
doctor
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Q5 - Decide

patient explicitly says that a decision was made

Q5 - Decide - Agree

patient says that the patient and physician agreed
on the decision

Q5 - Decide - Best for individual
patient

patient says that the decision was made in the
patient's best interest

Q5 - Decide - Decide together

patient says that the doctor and patient decided
together

Q5 - Decide - Pt decides

patient says that they made the decision

Q5 - Rapport

patient brings up the concept of relationship or
rapport

Q6 & Q7

When asked about SDM in general…

Q7 - Info

patient brings up the concept of sharing or
exchanging information

Q7 - Info - Dr shares info

patient says that doctors should share information

Q7 - Info - Dr shares info - gives
opinion

patient says that doctors should give their opinion

Q7 - Info - Dr shares info - gives
options

patient says that doctors should share options

Q7 - Info - Dr shares info recommend

patient says that doctors should make a
recommendation

Q7 - Info - Dr shares info recommend - no demand

patient says that physicians should not make
demands or ultimatums when making
recommendations

Q7 - Info - Pt shares info

patient says that patients should share information

Q7 - Info - Pt shares info - gives
opinion

patient says that patients should share their
opinion

Q7 - Info - Pt shares info shared symptoms/problem

patient says that patients should share any
relevant symptoms or problems

Q7 - Info - Pt shares info - asks
questions

patient says that patients should ask questions

Q7 - Info - Pt shares info expresses concerns

patient says that patients should express their
feelings or concerns

Q7 - Listen

patient explicitly brings up the concept of listening

Q7 - Listen - Dr listens

patient explicitly says that doctors should listen to
patients

Q7 - Listen - IMPLIED

patient does not use the word "listen", but listening
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is implied in the process that they describe
Q7 - Listen - Pt listens

patient explicitly says that patients should listen to
doctors

Q7 - Decide

patient brings up the concept of a making a
decision

Q7 - Decide - Agree

patient says that doctors and patients should come
to an agreement

Q7 - Decide - Best for patient

patient says that doctors and patients should make
a decision in the best interest of the patient

Q7 - Decide - Decide together

patient says that doctors and patients should
decide together

Q7 - Decide - Pt decides

patient says that the patient ultimately decides

Q7 - Rapport

patient brings up the concept of relationship or
rapport

Q7 - Rapport - Dr knows pt

patient says it is important for the doctor to know
the patient before making recommendations

Q7 - Rapport - Honesty

patient brings up the concept of honesty

Q7 - Rapport - Respect

patient brings up the concept of respect

Q7 - Rapport - Trust

patient brings up the concept of trust

Q7 - OTHER - Accessibility

patient says that accessibility of the doctor outside
of the visit is important

Q7 - OTHER - Choice

patient says that they should be offered choice

Q7 - OTHER - Pt allowed time

patient says that patients should be allowed time to
make decisions

Q7 - OTHER - Pt follow-through

patient says that the patient needs to follow
through with actions required by the decision

Q7 - OTHER - Pt take
responsibility

patient says that patients need to take
responsibility for their decisions and/or health

Q7 - OTHER - Pt understands

patient says it is important that patients understand
the decision at hand

Q9

When asked what things patients must do during
the conversation for it to be considered a
shared decision…

Q9 - Ask for second opinion

patient says they should ask for a second opinion if
needed

Q9 - Ask questions

patient says they should ask questions
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Q9 - Be honest

patient explicitly listed being honest

Q9 - Be open-minded

patient says they should be -open-minded to the
physician's opinion and/or recommendation

Q9 - Be prepared

patient says they should come prepared for the
visit

Q9 - Direct doctors to topic of
interest

patient says they should direct doctors to the
topics they want to discuss

Q9 - Express opinions

patient says they should express their opinions if
they have one

Q9 - Make decision

patient says they should ultimately make the
decision

Q9 - Share info

patient says they should provide all relevant
information

Q9 - Speak up

patient says they should speak up if uncomfortable
with decision or recommendation

Q10

When asked what things doctors must do during
the conversation for it to be considered a
shared decision…

Q10 - Answer pt questions

patient says that doctors should answer patient
questions or address concerns

Q10 - Be honest

patient explicitly says that the doctors should be
honest with patients

Q10 - Be open-minded

patient says that doctors should be open-minded
to patient requests and opinions, being willing
to stray from usual approach

Q10 - Check for agreement

patient says that doctors should check for patient
agreement and understanding

Q10 - Give information

patient says that doctors should give information to
patients

Q10 - Give reasons for
recommendation

patient says that doctors should check for patient
agreement and understanding

Q10 - Know patient

patient says that doctors should get to know
patients before making recommendations

Q10 - Listen to patient

patient says that doctors should listen to patients

Q10 - Provide options

patient says that doctors should provide patients
with options
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Q10 - Respect

patient says that doctors should respect the
patients

Q10 - Share opinion

patient says that doctors should share their opinion
with patients

Q10 - Solicit involvement

patient says that doctors should solicit patient
questions, concerns, symptoms

Q10 - Take time

patient says that doctors should take the time to
have a conversation with patient and not rush

Q10 - Understand patient
symptoms/concerns

patient says that doctors should understand patient
symptoms and concerns
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